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 Summary of MRP 
 
Section A identifies and critically evaluates existing tools for assessing cognitive impairment 
in people who have experienced an acquired brain injury. The clinical utility and 
psychometric properties of each measure is discussed and recommendations are made for the 
need for further validation of these measures or the development of a new comprehensive 
assessment tool. 
 
Section B is a psychometric validation study of a new neuropsychological assessment: the 
SPANS. The internal reliability, discriminative validity, classification accuracy, and factor 
structure of the measure was assessed. 
 
Section C provides a critical and reflective account of the research process and the authors 
own learning. Directions for future research and clinical implications of the study are also 
considered. 
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Abstract 
Assessment of cognitive functioning following an acquired brain injury is an important aspect 
of neuro-rehabilitation services and can help guide treatment planning. Due to resource 
limitations in services and patients’ difficulty tolerating lengthy assessments due to factors 
such as fatigue, there is a need for brief but comprehensive measures of cognitive function 
that can be easily administered by a range of health professionals. The current review aimed 
to identify and critically evaluate the psychometric properties of existing brief but 
comprehensive measures of cognitive function that have been validated in an acquired brain 
injury population. The literature search identified 15 papers covering four different tests: 
Addenbrooke's Cognitive Examination – Revised (ACE-R); the Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS); the Cognistat; and the 
Neuropsychological Assessment Battery - Screening Module (NAB-SM). The review found 
that there is some evidence to support the use of the RBANS or NAB-SM with people with 
an acquired brain injury, though these measures have limitations in terms of construct validity 
and reliability of indices respectively. Further research is required to increase the evidence 
base for the use of either of these measures with people with an acquired brain injury. 
Alternatively, a new purpose-designed tool could be developed that aims to address the 
limitations of existing measures. 
 
Keywords: Acquired brain injury, neuropsychological assessment, psychometrics, cognitive 
impairment, screening tools 
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Introduction 
Acquired brain injury: 
Acquired brain injury (ABI) refers to any injury to the brain that has occurred since birth (i.e. 
is not a neurodevelopmental disorder) and is non-degenerative (Headway: the brain injury 
association). It includes traumatic brain injuries (TBI), such as those resulting from a road 
traffic accident or assault, and non-traumatic injuries, for example cerebrovascular accidents 
(stroke). According to the World Health Organisation [WHO], (2006) neurological disorders 
contribute 6.3% to the global burden of disease. The second most common cause of death 
worldwide is accounted for by strokes (Sarti, Rastenyte, Cepaitis, & Tuomilehto, 2000), 
whilst TBIs are responsible for the majority of deaths and disability in children and young 
adults (WHO, 2006). In the UK alone, it is estimated that there are approximately 950,000 
working-age adults living with on-going impairments as a result of TBI or stroke (Headway: 
the Brain Injury Association). 
 
Cognitive impairment: 
Cognitive complaints are common following an ABI. Approximately 60% of people who 
have suffered a stroke will experience some level of cognitive dysfunction (Jin, Legge, 
Ostbye, Feightner, & Hachinski, 2006). Research has demonstrated a linear relationship 
between injury severity and extent and persistence of cognitive dysfunction (Dikmen, 
Machamer, Winn, & Temkin, 1995). Impairments may include confusion, disorientation, 
attention deficits, memory problems, language and communication difficulties, impaired 
judgement, poor organisation and planning, and inflexibility of thinking (Wallesch, Curio, 
Galazky, Jost, & Synowitz, 2001). Early cognitive status is predictive of overall outcome and 
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can determine the need for further rehabilitation or care post-discharge (Dikmen, McLean, 
Temkin, & Wyler, 1986). Greater cognitive impairment is associated with the risk of poor 
return to work (Shames, Treger, Ring, & Giaquinto, 2007) and limited community integration 
(Kneipp & Rubin, 2007).  
 
Neuropsychological assessment: 
Neuropsychological assessment is “the normatively informed application of performance-
based assessments of various cognitive skills” (Harvey, 2012, p. 91). It has been shown to 
affect the management of patients and improve outcomes (Chelune, 2010). Due to individual 
differences in functional neuroanatomy (Heilman & Valenstein, 2003), assessment is 
essential to describe the cognitive-behavioural expression of an injury for that individual 
(Schoenberg, 2011). As well as providing information on how a person might cope with 
medication regimes (Hinkin et al., 2002), driving (Schanke & Sundet, 2000), or self-care 
(McCue, Rogers, & Goldstein, 1990); neuropsychological assessments have also been shown 
to be predictive of employment outcome (Ponsford et al., 2008), likelihood of seizures 
(Sawrie et al., 1998), and risk of further cognitive decline (Herrmann, Goodwin, & Ebmeier, 
2007).  
 
Psychometric theory 
For neuropsychological assessments to be meaningful, the knowledge they produce must be 
reliable and valid. To prove that this is the case, tests must be validated using psychometric 
methods (Anastasi & Urbina, 1997; Russell, Russell, & Hill, 2005). Reliability means that 
any change in scores is due to change in the construct being measured, as opposed to random 
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error or influence of confounding variables. Reliability is not an absolute property of tests but 
one of degree that must be assessed with different populations in different contexts 
(Schoenberg, 2011). Validity refers to the extent that the test measures what it claims to. It is 
a property not of the test itself, but the conclusions drawn from the test (Schoenberg, 2011). 
Evidence for validity is generally considered within a tripartite model consisting of: content; 
construct (convergent/divergent); and criterion-related (predictive/concurrent) evidence 
(Schoenberg, 2011; Anastasia & Urbina, 1997). An example of criterion-related evidence is 
classification accuracy statistics (or diagnostic validity – these are described in more detail in 
the literature review). 
 
Another principal of neuropsychological assessment is normative comparison (Harvey, 
2012). Clinicians need to know how a comparable person would be expected to score on a 
test in order to infer whether a patient’s performance is outside normal limits. If assessing 
multiple domains, clinicians need to know what degree of variability is normal. If normative 
data are not representative of the patient being assessed, interpretation may be invalid. 
Similarly, if tests have not been normed on a single sample (as is the case in flexible batteries 
that pool different tests), comparing test scores is invalid (Harvey, 2012). This is one of the 
key reasons why Russell et al., (2005) argue that flexible batteries undermine the 
fundamental principles of neuropsychological assessment and conclude that fixed and co-
normed batteries should be employed. 
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Clinical practice: 
In reality it is not practicable for every patient to undergo a full neuropsychological 
assessment. Issues of fatigue and attention deficits make participating in lengthy testing 
problematic for patients (McKay, Wertheimer, Fichtenbery, & Casey, 2008). Rapid changes 
in the early stages following an ABI may render cognitive assessments obsolete, whilst 
assessing towards the end of admission does little to inform treatment planning (Nabors, 
Millis, & Rosenthal, 1997). Furthermore, resource issues have resulted in a trend for 
decreasing lengths of stay in hospitals and rehabilitation settings (Nabors et al., 1997), as well 
as limiting access to neuropsychological expertise (McMillan & Ledder, 2001). These 
pressures have resulted in a need for neuropsychological measures that can identify the 
presence of cognitive impairment and the specific domains affected (Lezak, 2004). For 
clinical utility, the tool needs to be quick and easy to administer by any health care 
professional, be repeatable in order to document change, and have the potential to guide 
recommendations for rehabilitation (Nabors et al., 1997). 
 
Rationale for review: 
There is a need for brief but comprehensive and psychometrically sound neuropsychological 
assessments that can be used to determine cognitive function in patients who have had an 
ABI. Though reviews have been conducted about screening tools for dementia (Cullen, 
O’Neill, Evans, Coen, & Lawlor, 2007), neurobehavioural disability (Woods, Alderman, & 
Williams, 2008) and executive function (Poulin, Korner-Bitensky, & Dawson, 2013), 
currently there does not exist any review of tools for ABI. This current review therefore aims 
to search the literature to identify and critically evaluate the psychometric properties of 
neuropsychological assessments which have been researched with an ABI population. 
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Methods: 
A literature search was conducted which resulted in 15 papers to be included in this review 
(see Appendix A). Neuropsychological tests (NTs) were included if they: 1) were designed to 
assess for cognitive impairment in multiple domains and provide separate scores for each 
domain; 2) were performance-based measures given direct to patients; 3) could be 
administered in one hour or less; and 4) had been published in English. Individual 
standardised tests, flexible batteries, standardised batteries with administration times of over 
one hour, tests which only give a global score, or unpublished tests were excluded. 
 
Papers relating to each measure were included if: a) the main aim of the study was to 
investigate the psychometric properties of the test; and b) participants were predominantly 16 
– 65 years old, English-speaking, with an ABI. Studies including older adults were retained if 
the mean age was less than 65 years old. Studies conducted solely with children and 
adolescents or older adults were excluded. Studies with neurodevelopmental or 
neurodegenerative conditions or physical illnesses with associated cognitive impairments 
(e.g. HIV) were also excluded. 
 
Literature search results: 
Four tests discussed in 15 papers were identified which met the selection criteria: 
Addenbrooke's Cognitive Examination - Revised (ACE-R: Mioshi, Dawson, Mitchell, 
Arnold, & Hodges, 2006); the Repeatable Battery for the Assessment of Neuropsychological 
Status (RBANS: Randolph, 1998); the Cognistat (formerly Neurobehavioural Cognitive 
Status Examination: Kiernan, Mueller, Langston, & Van Dyke, 1987); and the 
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Neuropsychological Assessment Battery - Screening Module (NAB-SM: Stern & White, 
2003). For each test, a brief description of the design and development is provided1 followed 
by a critical evaluation (based on guidelines by Fritz & Wainner, 2001; Greenhalgh, 1997; 
and Jaeschke, Guyatt, & Sackett, 1994) of the psychometric research with ABI populations. 
Key information for each test can be seen in Table 1 for ease of comparison (see Appendix B 
for a more detailed summary). 
  
                                                          
1
 Where this information was not available through the retrieved articles a supplementary PsychINFO search 
was conducted using the individual test name in order to identify the original validation paper. 
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Table 1: Summary of key information for each test 
 ACE-R RBANS NAB-SM Cognistat 
Designed for: Dementia screen Dementia screen Generic 
cognitive screen. 
Determine need 
for full NAB 
 
Generic 
cognitive screen. 
Normative 
data: 
N =  63, aged 50 
-75, 12.7 years 
education (not 
age/education 
scaled) 
N = 540, aged 
20-89; age-
scaled scores and 
information on 
education effects 
provided 
 
N= 1,448; age, 
gender and 
education scaled-
scores provided 
N = 116 adults, 
aged 20 to 92 
Admin time: Mean 15 mins 20-30 mins 24-45 mins 20-30 mins 
 
Constructs 
measured: 
A/O; M; VF; L; 
V. 
A; IM; DM; L; 
V 
A; M; L; S; EF LoC; O; A; M; 
L; C; Cal; R 
 
Reliability 
(Cronbach’s α) 
- IM: 0.75; V: 
0.76; 
L 0.33; A: 0.16; 
DM: 0.77;  
Total: 0.84 
 
A 0.39, L: 0.4,  
M: 0.42, S: -
0.14, EF: -0.37. 
Total: 0.60 
0.71 person 
separation index 
0.90 item 
separation index 
Classification 
statistics 
Sensitivity:    
100%, 72%, 
56% 
Total Score: 
Sensitivity: 0.82 
Specificity: 0.94  
LR:13.7 
PPV; NPV; 
OCC: 
95.5; 78; 87.1 
 
- - 
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Construct 
validity 
- Partial evidence 
for convergent & 
divergent 
validity, except 
for ‘A’. 
PCA: 2-factors 
 
Partial evidence 
for convergent & 
divergent 
validity, except 
for EF. 
Partial evidence 
for convergent 
validity, except 
for ‘R’. 
Criterion 
validity 
- Predictive: 
predicts FIM-cog 
& FAI scores. 
Concurrent: 
significant 
different scores 
left/right 
hemisphere 
stroke 
Concurrent: 
Associated with 
FIM and MPAI-
4 
- 
  
A= Attention, O= Orientation, M= Memory, VF= Verbal Fluency, L= Language, 
V= Visuospatial, IM= Immediate Memory, DM= Delayed Memory, S= Spatial, EF= Executive 
Functioning, LoC= Level of Consciousness, C= Construction, Cal= Calculation, 
R= Reasoning, LR= Likelihood Ratio, PPV= Positive Predictive Value, NPV= Negative 
Predictive Value, OCC= Overall Classification Correct, PCA= Principal Component 
Analysis, FIM-Cog= Functional Independence Measure-Cognitive, FAI = Frenchay Activity 
Index, MPAI-4= Mayo-Portland Adaptability Inventory-4. 
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 ACE-R 
Design & development: 
The ACE was designed to screen for and distinguish between frontotemporal dementia and 
Alzheimer’s disease (Mathuranath, Nestor, Berrios, Rakowicz, & Hodges, 2000). It was later 
revised (ACE-R) in order to improve ease of administration, sensitivity, ceiling effects, and to 
create parallel versions (Mioshi et al., 2006). A substantial body of research exists 
demonstrating the clinical utility and validity of the ACE-R for diagnosing dementia (for a 
review see Queally, Evans, & McMillan, 2011). The test also incorporates the Mini Mental 
State Examination (MMSE: Folstein, Folstein, & McHugh, 1975). It does not require 
additional equipment. 
 
ABI studies: 
One validation study has been conducted using the ACE-R in a working-age TBI population 
(Gaber, 2008). The sensitivity for both the ACE-R and MMSE scores were calculated at three 
different cut-offs drawn from the normative scores published in Mioshi et al., (2006). The 
ACE-R demonstrated better sensitivity at each cut-off compared to the MMSE. T-tests 
showed significant (p<0.001) differences between the MMSE, ACE-R total and ACE-R 
domain scores in this study and the Mioshi et al., (2006) normative data. One assumes that 
the ABI group was more impaired than the normative sample, though the paper does not state 
this. The authors conclude that the MMSE is not suitable for cognitive screening in ABI due 
to its insensitivity in detecting gross cognitive impairment but that the ACE-R has adequate 
sensitivity and can provide useful clinical information about the specific nature of difficulties. 
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Summary & critique 
The authors acknowledge that the normative sample used for comparison on the current study 
had an older mean age (64.4 years) and more years of education (12.7). Whilst significant age 
effects have not been found in other studies (Mioshi et al., 2006; Larner, 2007), this may be 
due to restricted range and small sample sizes.  Given that age effects are well established in 
other NTs (Lezak et al., 2004), obtaining normative date for a younger population seems 
necessary. The current study provides initial support for the practicality of using the ACE-R 
in a rehabilitation setting. However, it is limited in that it does not include a non-ABI control 
group to calculate specificity or predictive power.  
 
RBANS 
Design & development 
The RBANS was also designed for the purpose of diagnosing and differentiating different 
subtypes of dementia in older adults and numerous studies have demonstrated its validity for 
this task (e.g. Randolph, 1997; 1998; Randolph, Tierney, Mohr, & Chase, 1998). Validation 
studies have also been conducted with other populations (e.g. Beatty et al., 2003; Aupperle, 
Beatty, Shelton, & Gontkovsky, 2002; Moser m& Schatz, 2002). The RBANS comprises 12 
subtests which form five indices. It can be done at bedside and alternate forms are available.  
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ABI Studies 
Reliability 
One study has reported the internal reliability (Cronbach’s α) of the RBANS in a TBI sample 
(McKay, Casey, Wertheimer, & Fichtenberg, 2007). As hypothesised, strong internal 
reliability was found for the Immediate/Delayed Memory, Visuospatial, and Total Scale 
Index scores. Weak internal reliability was found for Attention and Language Index scores as 
the subtests that make up these indexes are known to have differential sensitivities to the 
detection of brain damage (McKay et al., 2007). 
 
Classification accuracy 
The sensitivity of the RBANS to detect cognitive changes following a stroke was initially 
demonstrated by Duff, Beglinger, Jenks-Kettmann, and Bayless (2006) in their case study of 
a 22 year old woman with a complex psychiatric history who had suffered a right-hemisphere 
stroke. The RBANS and a battery of other NTs were administered pre and post-stroke and 
standardised change scores calculated. The largest decline was in the Visuospatial Index, in 
keeping with research on right hemisphere strokes (e.g. Jordan & Hillis, 2005). A similar 
pattern of changes was observed with the other NTs supporting the convergent validity of the 
RBANS. However, Reliable Change Index (RCI: Jacobson & Truax, 1991) scores are not 
reported so the significance of the change scores is unclear.  
 
McKay, Wertheimer, Fichtenberg, and Casey (2008) compared performance on the RBANS 
between TBI patients and a matched clinical comparison group without ABI. They calculated 
the sensitivity (true positive rate), specificity (true negative rate), likelihood ratio (LR: 
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sensitivity/1-specificity), positive predictive value (PPV: proportion of positives that are true 
positives), negative predictive value (NPV: proportion of negatives that are true negatives) 
and overall correct classification (OCC: proportion correctly classified both positive and 
negative) at two cut-offs for RBANS Index and Total scores. Sensitivity and LRs ranged 
from modest to strong whilst specificity was high. Best performance was found for the Total 
score, with an OCC of 87.1%. The Attention Index was particularly sensitive, but had low 
specificity; the reverse pattern was true for the Visuospatial Index. An explanation of 
classification statistics would facilitate comprehension for readers unfamiliar with these. 
 
Construct validity 
The construct validity of the RBANS with ABI, stroke, and TBI patients is partially 
supported by Pachet (2007), Larson, Kirschner, Bode, Heinemann, and Goodman (2005) and 
McKay et al., (2007) respectively. Pachet (2007) found significant correlations between 
RBANS subtests and all matched NTs except RBANS Figure Copy/Recall and the Rey 
Complex Figure Test (RCFT: Meyers & Meyers, 1995). Only the Wechsler Memory Scale – 
III Digit Span correlated with RBANS Attention Index. Language subtests and Line 
Orientation were not included in this analysis, with no clear justification for this. Pachet 
(2007) concluded that the RBANS was not a strong measure of visual memory and that the 
Figure Copy/Recall and Coding subtests predominantly measure motor skills. McKay et al., 
(2007) similarly found moderate to strong correlations between RBANS subtests and NTs 
matched on basis of content and construct, with the exception of RBANS Figure Copy and 
the Benton Visual Retention Test (BVRT: Benton, 1974). 
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Larson et al., (2005) found that all RBANS Indices except Attention correlated significantly 
with NTs purported to measure the same construct, even whilst controlling for WAIS-R 
vocabulary scores (construed as a measure of general intelligence). The Attention Index 
showed a non-significant trend towards correlating with other tests of attention but was more 
strongly correlated with language tests, implying that this index may be a measure of general 
intelligence as opposed to attention. There was less evidence for divergent validity as the 
Attention, Visuospatial and Immediate Memory indices also correlated significantly with 
other language subtests, highlighting the RBAN’s reliance on verbal abilities. Importantly, 
the authors controlled for multiple comparisons using Bonferroni corrections, reducing the 
possibility of making a Type I error. However, their sample size was smaller than originally 
reported as only 70/158 completed all tests, reducing statistical power.   
 
Wilde (2006) also investigated RBANS construct validity through a principal components 
analysis which resulted in a two-factor solution accounting for 61% of the variance. This was 
termed a Language/Verbal Memory factor and a Visuospatial/Visual Memory factor. 
External validity of the factors was supported by significant correlations with NTs tapping 
similar constructs, as well as by the expected finding that left hemisphere stroke patients 
performed significantly worse on the Language factor and right hemisphere stroke patients 
performed significantly worse on the Visuospatial factor. The authors suggest that the five-
factor structure of the RBANS may not be valid for right and left hemisphere stroke patients 
for whom language and visuospatial impairments may obscure deficits in memory and 
attention (Wilde, 2006). Wilde (2010) expanded on this finding by examining the different 
subtest and Index scores for left, right, bilateral, cortical and subcortical stroke patients using 
multivariate analysis of variance (MANOVA).  As expected, left hemisphere patients were 
more impaired on Language; right hemisphere patients were more impaired on Visuospatial. 
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However, the results also suggested that impairments on Memory and Attention may be 
largely due to language deficits and the authors concluded that Attention Index has limited 
utility for stroke patients. The follow up study encompassed participants from the original 
study, therefore one might expect the same pattern of results to emerge. A validation study on 
an independent sample is needed to replicate these findings. 
 
Predictive validity 
Regarding predictive validity, Larson et al., (2005) found that the RBANS Total and Index 
scores (except Attention) at admission predicted cognitive outcome, as measured by the 
Functional Independence Measure (FIM: Hamilton, Granger, Sherwin, Zielzny & Tashman, 
1987), at 12 month follow-up. The Visuospatial Index was also found to significantly 
correlate with activities of daily living, as measured by the Frenchay Activity Index (FAI: 
Holbrook & Skilbeck, 1983). Motor functioning, as measured by the motor scale of the FIM, 
and participation restrictions, as measured by the Craig Handicap and Assessment Reporting 
Technique (CHART: Whiteneck, Charliufe, Gerhart, Overholser, & Richardson, 1992), were 
not predicted by RBANS Total or Index scores. Attrition in the study was high (over 50%) 
resulting in a small sample size, therefore regression analyses could not be conducted limiting 
the conclusions that can be drawn.  
 
Summary 
The above studies provide preliminary evidence for the internal reliability, diagnostic validity 
and construct validity of the RBANS in ABI populations. However, as the RBANS was 
designed to screen for dementia, the individual subtests may not be the most appropriate for 
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ABI, particularly those comprising the Attention Index. It appears that the five-factor 
structure of the RBANS is also not valid, at least for stroke patients, with a two-factor verbal 
and visual solution being more appropriate. Many of the studies recommend supplementing 
the RBANS with additional measures of attention and executive function in ABI; however 
this introduces the issue of comparing tests with different normative samples. 
 
NAB-SM 
Design & development  
In contrast to the tests reviewed so far, the NAB was developed to assess the cognitive 
abilities in adults aged 18 to 97 with the aim of detecting any central nervous system 
disorder. The full battery consists of 6 modules: a Screening Module and five domain-
specific modules. The NAB-SM contains identical or similar items to the NAB and was 
designed to be able to predict performance on the NAB. The NAB combines the advantages 
of both a fixed and flexible battery due to its co-norming approach, which means that the 
NAB-SM can be administered on its own or together with other modules as indicated. T-
scores can be calculated for subtest, index and total NAB-SM scores and it has a parallel 
form (White & Stern, 2003). 
 
ABI studies 
Reliability 
Zgaljardic and Temple (2010) evaluated the internal consistency of the NAB-SM in an ABI 
sample. Cronbach’s α was weak for each cognitive domain and satisfactory (0.60) for the 
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Total score. This suggests that clinicians should refer to subtest scores for interpretation, as 
Index scores may not be reliable indicators of their component subtests. One issue is that the 
study uses both versions of the NAB-SM with no separate analysis of each, so form 
equivalency cannot be assessed. 
 
Construct validity 
Zgaljardic and Temple (2010) computed correlations between NAB-SM Total and Index 
scores and NTs. Convergent and divergent validity was largely established, particularly for 
the Attention Index. However, the Executive Functions Index correlated with tests sharing a 
visuomotor component rather than tests of executive function. They also calculated the 
correlations between the NAB-SM subtests and matched and unmatched (in terms of content) 
NTs. Significant correlations were found with all matched tests except Delayed Shape 
Learning and Wechsler Memory Scale-3 (WMS-III) Visual Reproduction II. All unmatched 
NTs correlated with one or more NAB-SM subtest, with the exceptions of NAB-SM Digit 
Forward and NAB-SM Visual Discrimination. No corrections for multiple comparisons were 
made, increasing the possibility of making a Type I error. The authors concluded that the 
NAB-SM may be limited in screening for visual memory and executive function difficulties 
in an ABI population. 
 
Ecological validity 
Temple et al., (2009) and Zgaljardic, Yancy, Temple, Watford, and Miller (2011) 
investigated the ecological validity of the NAB-SM in a TBI sample by examining its 
relationship with the FIM and Mayo-Portland Adaptability Inventory-4 (MPAI-4: Malec & 
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Lezak, 2003) respectively. Hierarchical regression analysis controlling for age and gender 
demonstrated that the NAB-SM total score was significantly associated with the FIM total, 
motor and cognitive scores, accounting for 26%, 11% and 53% of the variance respectively 
(Temple et al., 2009). The NAB-SM Spatial Index was also significantly associated with the 
FIM total, cognitive and motor scores; whilst NAB-SM Language and Memory Index scores 
were significantly associated with the FIM cognitive score only. The NAB-SM Attention and 
Executive Function Indices did not correlate with the FIM.  
 
Zgaljardic et al., (2011), using linear regression analysis, also found that the NAB-SM Total 
score was significantly associated with the MPAI-4 Total, Ability, and Participation scores, 
accounting for 9%, 9%, and 13% of the variance respectively. NAB-SM Spatial Index was 
also significantly correlated with the MPAI-4. However, in contrast to Temple et al., (2009), 
the Language and Memory Index scores did not correlate with the MPAI-4, whilst the 
Executive Function Index did. Divergent validity was also supported by the lack of 
significant associations between the NAB-SM and the MPAI-4 Adjustment score, a measure 
of affect. 
 
Summary and critique 
Whilst the NAB-SM Total score has adequate reliability, the Index scores do not which limits 
their clinical utility for cognitive profiling. The Executive Function Index in particular 
appears to have limited validity and may be measuring visuomotor processing skills. As 
executive impairments are common in TBI this is a major limitation of the screen. It appears 
that the NAB-SM is measuring constructs that map onto daily life functioning, which is 
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important in terms of informing rehabilitation, although the predictive validity of this is yet to 
be established through longitudinal studies.  
 
Cognistat  
Design & development  
The Cognistat was designed to screen for cognitive impairment across a range of neurological 
or neuropsychiatric disorders (Kiernan et al., 1987). The test employs a screen and metric 
approach whereby for each domain a challenging question is first administered and if this is 
passed a full score is given for that domain, with no need for further testing. However, 
Oehlert et al., (1997) suggested this approach may underestimate impairment and 
recommended administering the entire test. Index scores are calculated and rated as average 
or mildly/moderately/severely impaired. A Total score can also be calculated but is not rated. 
Due to equipment requirements patients must be sat upright. 
 
ABI Studies 
Measurement properties: 
Rasch rating scale analysis procedures (Rasch, 1980) were employed to evaluate 1) 
unidimensionality, 2) ability to characterise a useful range of cognitive function, and 3) the 
pattern of performance on cognitive domains of the Cognistat in a community TBI sample 
(Doninger et al., 2000). A series of calibrations resulted in three strata of performance, with 
the easiest item being Naming Objects and hardest being Delayed Recall. Rasch analysis 
suggested that the test was too easy for this sample and there were three misfitting items 
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which may be measuring alternative domains. A second analysis was run with a reduced 
item-set which created a less skewed test without increasing error. Analysis of the cognitive 
domains found that the Attention Index performed differently to the other domains, 
suggesting it may not be a good measure of general cognitive capacity.  
 
Doninger et al., (2006) replicated and extended this study to compare findings between 
inpatient and community TBI populations. Results were comparable between the two 
samples, with the exception of less pronounced ceiling effects in the inpatient group. Due to 
the large and overlapping range of injury onset and severity, the two groups may not be as 
distinct as implied. The authors conclude that whilst the Cognistat may be useful as a crude 
measure of general cognitive dysfunction, or to reveal unexpected performance patterns, it is 
inappropriate to use for cognitive profiling in either community or inpatient TBI populations. 
 
Construct validity 
Nabors et al., (1997) found significant correlations between Cognistat subtests and associated 
NTs with the exception of the Reasoning subtests and Wisconsin Card Sorting Test (WCST: 
Heaton, 1981). However, they followed the screen and metric approach to administration 
which may underestimate impairment and inflate correlations. Wallace, Caroselli, Scheibel, 
and High (2000) reported the same pattern of findings, though with slightly different matched 
NTs. They also reported a significant correlation between the number of impaired 
performances on the Cognistat and NTs. Overall classification agreement between the 
Cognistat and NTs was fair (0.79 accuracy), with high sensitivity (0.92) but low specificity 
(0.22).  However, at the subtest level classification agreement was interpreted as good for 
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Construction subtest only, all remaining subtests were in the poor range. The authors 
concluded that whilst the Cognistat may be useful in detecting the presence or absence of 
cognitive impairment, it should not be used for the purpose of describing an individual’s 
cognitive profile.  
 
Summary and critique 
The above studies highlight concerns with the measurement properties of the Cognistat when 
used with ABI populations. The test demonstrates ceiling effects, appears to have many 
redundant or poorly constructed items, and the validity of the screen and metric approach has 
been questioned. Whilst the measure may be able to differentiate three levels of cognitive 
function at a global level, it seems inappropriate for use in cognitive profiling. 
 
Discussion 
This review aimed to identify and evaluate the psychometric properties of brief but 
comprehensive NTs. Four measures were identified and reviewed. Whilst all measures have 
some preliminary evidence for their use in cognitive assessment of ABI, research is lacking 
and each has limitations. 
 
The ACE-R and RBANS were both designed specifically as a tool for screening for 
dementia. This is important in terms of the content validity of the measures, as the theoretical 
model of cognitive impairment in dementia differs from that for ABI. For example, in 
Alzheimer’s disease the temporal lobes are commonly affected, which is associated with 
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deficits in category fluency (Monsch et al., 1992); whilst in TBI frontal lobe damage is more 
common, resulting in deficits in letter fluency (Cummings, 1995). Therefore, the rationale 
behind test item selection will differ and items included in the RBANS and ACE-R may not 
be the most suitable for the purpose of cognitive assessment in ABI. 
 
Of the four measures reviewed, the NAB-SM provides the largest and most comprehensive 
normative data. Sample sizes for the normative data for both the ACE-R and Cognistat are 
relatively small, increasing the possibility of error and limiting generalizability. Scores are 
not scaled according to age, gender, or education level and the ACE-R normative sample are 
aged over 50 years, making comparisons in younger individuals problematic. As normative 
comparison is a fundamental principal in neuropsychological assessment (Harvey, 2012), 
having representative norms that have been stratified according to variables known to 
influence test performance is essential.  
 
All of the measures include an attention, memory, language and visuospatial/constructional 
component. The Cognistat also includes a Calculation and Reasoning Index, though the 
construct validity of the latter was not supported by the evidence from Nabors et al., (1997). 
Only the NAB-SM includes an Executive Function Index. Executive impairments are one of 
the most common sequelae of ABI (Lesniak, Bak, Czepiel, Seniow & Czlonkowska, 2008) 
and are associated with increased dependence (Lesniak et al., 2008), poorer return to work 
(Ownsworth & Shum, 2008) and decreased social participation  (McDowd, Filion, Pohl, 
Richards, & Stiers, 2003). Therefore it seems essential for any NT to include items purported 
to measure this construct. Whilst it is possible to supplement assessment with tests of 
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executive function such as the WCST, this introduces the problem of normative comparison 
and increases the chance of making invalid interpretations (Russell et al., 2005). 
 
Evidence for strong psychometric properties in an ABI sample is not well established for any 
of the measures reviewed. No studies have examined the reliability of the ACE-R. 
Cronbach’s α statistics were acceptable for the RBANS Immediate/Delayed Memory Index, 
Visuospatial Index, and Total Scale Index only (McKay et al., 2007). No α’s reached 
acceptable levels in the NAB-SM (Zgaljardic & Temple, 2010). This suggests that the 
Attention and Language RBANS indices and the NAB-SM Indices may not be valid 
indicators of the underlying subtest performance. Similarly, Doninger et al., (2000; 2006) 
found that the Cognistat could only reliably differentiate three different levels of performance 
at the global level, not cognitive domain level. 
 
The fact that information about classification accuracy is currently unavailable for ACE-R, 
NAB-SM and Cognistat significantly limits the clinical utility of these measures with ABI 
populations. Classification accuracy statistics were acceptable for the RBANS Total score 
(McKay et al., 2008) but not for the individual Index scores. This is not an issue for diagnosis 
of brain dysfunction (as individual indices would not be used for this purpose). However, it 
would be useful to know the classification agreement between the Index scores on these 
measures and corresponding scores on gold standard NTs. This information is only reported 
for the Cognistat (Wallace et al., 2000), with poor agreement found between most items. 
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In general, more evidence is needed for both construct and criterion related validity for all the 
included measures. Whilst significant correlations have been found between most subtests 
and indices and other matched NTs, providing evidence for convergent validity, this is 
weaker for the RBANS Attention Index, NAB-SM Executive Function Index, and Cognistat 
Reasoning Index. Evidence for divergent validity is more variable. This may indicate a 
shared variable (e.g. general intelligence) across many items. Predictive validity has only 
been evaluated with the RBANS (Larson et al., 2005). Though the NAB-SM has been shown 
to relate to functional abilities concurrently (Temple et al., 2009; Zgaljardic et al., 2011), 
longitudinal studies are needed to evaluate the predictive validity of this measure. 
 
The RBANS or the NAB-SM seem most suitable for assessing cognitive impairment in ABI. 
RBANS has the advantage of better reliability and a more extensive evidence base including 
classification statistics and predictive validity. However, it was originally designed as a 
dementia screen; its five-factor structure is not supported; and it does not measure executive 
function. The NAB-SM has the advantage of being designed as a generic screen and 
including an Executive Function Index. However, the construct validity of this Index has 
been questioned; reliability is poor; and no information is available on classification 
accuracy. 
  
Future research 
One avenue for future research is to add to the existing psychometric evidence base for the 
RBANS and NAB-SM. Evidence of other forms of reliability is needed. Information about 
the classification accuracy is required for the NAB-SM. Construct validity could be further 
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assessed by investigating the relationship between the NAB-SM and the NAB. Validation 
and comparison against a wider variety of other NTs, functional abilities or measures, and 
outcome measures is also indicated, as well as comparison of the RBANS and NAB-SM 
themselves. Longitudinal studies to assess change over time, practice effects and relationship 
with long-term outcomes would also further the evidence base. All of the above could be 
done with a variety of ABI populations to investigate the impact of, for example, cause and 
severity of injury. 
 
A second avenue for future research would be to design and develop a new tool for assessing 
cognitive abilities in ABI. The advantage of this avenue is that the tool could be purpose-
designed for ABI populations, with test items selected based on theoretical models of ABI 
and the existing literature on known cognitive sequelae. The test would need to be designed 
with the aims of addressing the limitations of the existing measures, for example reducing 
floor and ceiling effects, providing adequate normative data, and demonstrating acceptable 
reliability and validity.   
 
Conclusions 
This review has identified and critically evaluated the psychometric properties of four 
cognitive assessments used in ABI. It has concluded that the RBANS and NAB-SM show the 
most promise for this purpose, but both have significant limitations. Future research should 
aim to increase the evidence base for either of these measures with ABI. Alternatively, a new 
ABI-specific tool could be developed that aims to address the limitations of the existing tools. 
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Abstract 
 
Cognitive complaints are common following an acquired brain injury and require careful 
assessment in order to guide treatment and care. There is a need for brief, comprehensive and 
psychometrically valid tests of cognitive function that can be used in neuro-rehabilitation 
services by a range of health professionals. The Short Parallel Assessment of Cognitive 
Status (SPANS) was purpose-designed to meet this need. The current study assessed the 
reliability, discriminative validity and factor structure of the SPANS. Participants were 61 
people with an acquired brain injury, 35 people with a long-term neurological condition, and 
122 healthy controls. Cronbach’s alphas were adequate to excellent for the clinical groups 
though poor for the healthy controls due to limited variance in the scores. Receiver operating 
characteristic curves showed that SPANS indices were significantly able to discriminate 
between people with a neurological condition and healthy controls as well as between left and 
right hemisphere damage. Exploratory factor analysis suggested the retention of 25 subtests 
representing three factors that largely followed the purported structure of the test: Memory 
and Learning, Language, and Visual-motor Performance. Limitations of the study, 
clinical/theoretical implications and research directions are considered. It is concluded that 
the SPANS is a reliable and valid tool for the assessment of cognitive function in people with 
an acquired brain injury, though further validation studies are required. 
 
Keywords: Neuropsychological assessment, screening tool, cognitive impairment, 
psychometrics, acquired brain injury  
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Introduction 
Acquired brain injury (ABI) is the term used for any injury to the brain that has occurred 
since birth and is non-degenerative (Headway: the brain injury association). People present to 
services with a complex array of difficulties following ABI, including physical disability, 
cognitive impairment, behavioural problems and issues with social and daily-life functioning 
(Turner-Stokes, Nair, Sedki, Disler, & Wade, 2011). Cognitive impairment is common and 
may include difficulties with memory, attention, processing speed, language, visuo-spatial or 
perceptual abilities, and executive function (Williamson, Scott, & Adams, 1996; Hanks, 
Ricker, & Millis, 2004; King & Tyerman, 2003; Lesniak, Bak, Czepiel, Seniow, & 
Czlonkowska, 2008). General theoretical frameworks in neuropsychology distinguish 
between cognitive functions that have a distributed neural basis, such as attention, memory, 
and executive functions, and cognitive functions that are more localised neuroanatomically, 
such as language (Hodges, 1999). Both diffuse and localised damage can occur following 
ABI resulting in complex symptomatic presentations (Kreutzer, Gordon, Rosenthal, & 
Marwitz, 1993). 
 
Studies have shown that early cognitive status is associated with the ability to benefit from 
further rehabilitation, need for post-discharge support, and overall outcome (Dikmen, 
McLean, Temkin, & Wyler, 1986). The results of neuropsychological assessments can inform 
treatment planning and improve outcomes for patients and medico-legal clients (Chelune, 
2010). Therefore, an important role for clinical psychologists working in neurorehabilitation 
services is the objective assessment of cognitive dysfunction using standardised 
neuropsychological measures (Harvey, 2012). Cognitive assessment needs not only to take 
account of the broad range of cognitive domains highlighted above, but also their constituent 
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parts. For example, Sohlberg and Mateer (1989) described five aspects of attention in order of 
increasing difficulty: focused, sustained, selective, alternating, and divided. Information 
processing theories of memory generally describe three key processes: encoding, 
consolidation and retrieval, which are further subdivided into different sensory modalities, 
such as verbal and visual (e.g. Schoenberg, 2011) Comprehensive assessment is therefore 
essential. 
 
The most common approach to assessing cognition in clinical practice is using a flexible 
battery (i.e. a collection of individually standardised tests) to measure a range of different 
cognitive constructs (Kosaka, 2006; Rabin, Barr, & Burton, 2005; Sweet, Nelson, & Moberg, 
2006). However, this approach has been criticised (Russell, Russell, & Hill, 2005) for not 
adhering to one of the fundamental principles of neuropsychological assessment, namely the 
reliability of measurement and the application of psychometric theory. Russell et al. (2005) 
argued that clinicians should therefore employ fixed or standardised batteries that have been 
co-normed and validated as a whole (for alternative views see Bigler, 2007 and Larrabee, 
2008). Resources in public health services are limited. Patients are often unable to tolerate 
much testing due to factors such as fatigue and confusion. In the early stages of recovery (e.g. 
emerging from post-traumatic amnesia), health and cognitive status changes rapidly, 
rendering test results quickly obsolete. Together, this means that a test battery, as well as 
being psychometrically reliable and valid, also needs to be brief, repeatable and able to be 
delivered by a range of health professionals (Nabors, Millis, & Rosenthal, 1997). An 
accessible, comprehensive, co-normed and validated measure is required. 
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Review of existing brief comprehensive measures 
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was 
originally designed and validated as a screen for dementia (Randolph, 1997) but has since 
been used for a number of other clinical groups, including ABI. Internal reliability has been 
shown to be acceptable with a traumatic brain injury (TBI) sample for all indices, bar 
Language and Attention (McKay, Casey, Wertheimer, & Fichtenberg, 2007). Its 
classification accuracy (i.e. ability to diagnose cognitively impaired versus healthy controls) 
was adequate when using the Total Scale Index (McKay, Wertheimer, Fichtenberg, & Casey, 
2008) but the individual indices were less discriminatory. Partial support for convergent and 
divergent validity with existing similar measures was found in a number of studies (Pachet, 
2006; Larson, Kirschner, Bode, Heinemann, & Goodman, 2005; McKay et al., 2007), and the 
RBANS was shown to predict cognitive outcome and activities of daily living at 12 month 
follow up (Larson et al., 2005). However, as the test items were chosen with the aim of 
detecting dementia, not all items were deemed sensitive to the type of brain dysfunction 
commonly found following ABI (McKay et al., 2007) and important cognitive domains, such 
as executive functioning, are not assessed. The Attention and Visual Memory components of 
the RBANS have also been criticised as not measuring what they purport to (Pachet, 2006) 
and Wilde (2006) demonstrated with principal component analysis that a two-factor solution 
(verbal reasoning/memory and visual reasoning/memory) was more interpretable than the 
proposed five-factor structure of the test.  
 
The Neuropsychological Assessment Battery Screening Module (NAB-SM) has the 
advantage of being designed to screen for a range of cognitive abilities related to any central 
nervous system condition (Stern & White, 2003). However, internal reliability has been 
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reported as inadequate for both domain and total index scores, suggesting that the test items 
may not be measuring unitary constructs (Zgaljardic & Temple, 2010). Evidence for 
convergent and divergent validity has been reported (Zgaljardic & Temple, 2010); although 
the Executive Function Index appeared to be more strongly associated with tests of 
visuomotor processing than traditional tests of executive function. There is partial evidence 
for ecological validity in terms of veridicality, or correlation with measures of real-world 
functioning (Chaytor & Schmitter-Edgecombe, 2003), as the NAB-SM correlates with other 
functional measures (Temple et al., 2009; Zgaljardic, Yancy, Temple, Watford, and Miller, 
2011), with the exception of the Attention and Executive Function Indices. A significant 
limitation of the NAB-SM is the lack of information about its classification accuracy either in 
relation to brain dysfunction compared to healthy or other clinical groups, or in relation to 
results of the full NAB. 
 
The Short Parallel Assessments of Neuropsychological Status (SPANS) 
The SPANS (Burgess, 2013) is a newly developed brief but comprehensive 
neuropsychological battery which was designed with the aims of 1) addressing the design and 
psychometric limitations of existing test batteries used with working-age ABI populations, 2) 
creating a repeatable test that could provide information relevant to typical referral questions 
in neurorehabilitation services and 3) being practical for use in both in-patient and 
community settings.  
 
Relevant cognitive functions to assess were identified through a thorough review of the 
empirical and theoretical literature on common cognitive sequelae following ABI. For 
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example, spatial and object perception have distinct neuroanatomical pathways, so screening 
for both was deemed necessary (Warrington & James, 1991). Language tends to be 
represented predominantly in the left hemisphere, whilst visuo-spatial abilities are 
predominantly lateralised to the right hemisphere (Kolb & Whishaw, 2003), therefore 
including both visual and verbal tests can inform on localisation of damage. Specific tests 
were chosen based on their evidenced clinical utility (e.g. discriminative validity), predictive 
power in regard to post-discharge outcomes, and ecological validity in terms of verisimilitude 
(face validity: Chaytor & Schmitter-Edgecombe, 2003). For example, a task such as learning 
a grocery list has obvious real-world implications, thereby increasing face validity and 
cooperation from patients. In terms of discriminative validity, research has shown that the 
most sensitive measures of ABI compared to normal functioning are more ‘ability-focused’ 
tests (Larrabee, 2008), such as verbal supraspan learning tests, memory tests such as Logical 
Memory or Visual Reproduction subtests of the Wechsler Memory Scales, or 
sequencing/processing speed tests such as Trail Making Test B (Powell, Cripe, & Dodrill, 
1991; Larrabee, 2008; Dikmen, Machamer, Winn, & Temkin, 1995). In comparison, tests of 
more ‘crystallised intelligence’ or semantic knowledge, such as the Information subtest of the 
Wechsler Intelligence Scales, tend to be poorer discriminators (Capruso & Levin, 1992). 
Hence subtests were chosen to maximise the sensitivity of the SPANS. 
 
The SPANS was developed in routine clinical practice which gives it the advantage of 
addressing both the practical needs (e.g. administrable at bedside) and the typical referral 
questions (e.g. determine cognitive strength and weaknesses, assess learning potential) 
received in neurorehabilitation services (for full details see Burgess, 2013). Initial evidence 
for the reliability and validity of the SPANS is reported in the test manual (Burgess, 2013). 
The current study aimed to extend these findings to further evaluate the SPANS. 
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Aims and Hypotheses 
1) A design aim in the development of the SPANS was to create reliable and meaningful 
index scales (Burgess, 2013). Therefore, it was hypothesised that the SPANS index scales 
would demonstrate high internal consistency for the clinical participant groups, both 
separately and combined, and for each parallel form separately and combined. As the SPANS 
was designed to detect cognitive impairment as opposed to variability in cognitive skills 
within a healthy population, it was further hypothesised that internal consistencies would be 
low within the healthy control group (as a result of limited variance within the scores). 
 
2) There is evidence that the SPANS was able to discriminate between individuals with an 
ABI or other neurological condition and healthy controls (Burgess, 2013). However, the 
current study aimed to explore this in more depth by establishing optimum cut-off scores and 
evaluating the classification accuracy of each index score. It was hypothesised that the 
SPANS index scores would demonstrate adequate sensitivity and specificity in detecting 
ABI. It was further hypothesised that the indices containing more ‘ability-focused’ tests of 
memory, learning or processing speed would demonstrate better discriminative power 
compared to indices containing more semantic-based knowledge, such as the Language Index 
(LAI) (Larrabee, 2008; Carpuso & Levin, 1992). . Finally, it was hypothesised that the LAI 
and Visual Performance Index (VPI) would discriminate between left and right hemisphere 
damage respectively. 
 
3) The final aim of the study was to assess the construct validity of the SPANS through 
exploration of the underlying factor structure and evaluation of the internal consistency of 
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any emerging factors. Although the SPANS includes seven index scores, two of these contain 
subtests that overlap with other indices, therefore it was hypothesised that five factors would 
emerge. 
 
Methodology 
Participants  
Participants were a subset2 of those recruited by Burgess (2013). Clinical participants were 96 
non-consecutive referrals to three neuropsychology services in the UK over a four-year 
period (2007-2011). The majority of these (n = 77) were given SPANS form A (as this was 
designed to be administered first); however a randomly selected subset (n = 19) received 
form B as part of the parallel test evaluation process. Participants with any type of ABI were 
included if they were able to complete the SPANS and cognitive assessment was warranted 
and relevant to the referral question. Patients with excessive fatigue, language, visual, or 
motor impairments were excluded. Demographic and injury related information was obtained 
by the multi-disciplinary team as part of usual clinical practice. The clinical sample was 
composed of two groups: 1) 61 patients with a diagnosis of an ABI within the last year (ABI) 
and 2) 35 patients with a long term neurological condition, including ABIs more than one 
year old and other non-ABI diagnoses such as multiple sclerosis (LTNC: see Table 1 for 
more details). Demographic information for the clinical and control groups can be seen in 
Table 2.  
 
 
                                                          
2
 Time two repeated measures data were not included hence the smaller sample size than Burgess (2013).  
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Table 1: Injury and severity information by clinical group and SPANS form 
 ABI(n= 61) LTNC (n= 35) 
Form A (n= 49) B (n= 12) A (n= 28) B (n= 7) 
TBI 24 6 9 4 
Anoxic/Hypoxic  5 4 0 2 
Subarachnoid/subdural 
Haemorrhage 
10 2 1 1 
Stroke/Other Haemorrhage 6 0 3 0 
Other ABI* 4 0 6 0 
Epilepsy 0 0 2 0 
Other Non-ABI** 0 0 6 0 
LH/RH/BI/UN*** 16/15/11/7 5/1/2/4 5/6/2/15 0/2/2/3 
Lowest GCS****: Mean (SD) 7.10 (3.48)      8.00 (3.83) 9.18 (4.69) 9.43 (4.58) 
Weeks since injury (ABI)/initial 
diagnosis (LTNC): 
Mean (SD) range 
10.17 (8.56) 
 3-42 
15.63 
(15.94)     2-
50 
254.00 
(145.89) 59-
525 
319.00 
(182.09) 76-
550 
* ‘Other ABI’ = hydrocephalus, viral encephalitis, and profound hypoglycaemia.  
** ‘Other Non-ABI’ = multiple sclerosis, brain tumour, developmental disorder, and 
unexplained conditions characterised by neuropsychological deficit. 
*** LH = left hemisphere; RH = right hemisphere; BI = bilateral; UN = undifferentiated 
****GSC = Glasgow Coma Scale (Teasdale & Jennett, 1974) = a measure of severity scored 
in the first days/weeks following ABI. A score of 13-15 represents a minimal-to-mildly 
severe ABI; 9-12 represents a moderately severe ABI; and 3-8 represents a severe ABI. This 
information was not collected for non-ABI patients.   
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Table 2: Demographic information by participant group and SPANS form 
 ABI(n= 61) LTNC (n= 35) Controls (n= 122) 
 
Form A (n= 49) B (n= 12) A (n= 28) B (n= 7) A (n= 61) B (n= 61) 
Sex M/F 38/11 11/1 20/28 5/2 37/24 26/35 
Age (yrs) mean 
(SD)  
44.92 
(15.47) 
45.25 
(14.33) 
38.54 
(12.20) 
49.57 
(11.82) 
51.59 
(14.99) 
42.46 
(18.37) 
Education 
Secondary 
College/vocational 
University 
 
17 
22 
10 
 
6 
5 
1 
 
8 
15 
5 
 
3 
3 
1 
 
26 
19 
16 
 
35 
20 
6 
WTAR * 
Mean (SD) 
n= 6 
103 
(14.17) 
n= 0 n= 17 
98.29 
(13.51) 
n= 2 
112.5 
(4.95) 
 
103.43 
(5.18) 
 
101.70 
(5.13) 
* WTAR = Wechsler Test of Adult Reading (Holdnack, 2001) 
 
The normative sample consisted of 122 healthy controls recruited between 2009 and 2013, 
50% of whom were randomly allocated to receive SPANS form B. The sample was 
composed of patient family members, NHS employees, and other contacts of the research 
team. Participants were included if they had a Wechsler Test of Adult Reading (WTAR: 
Holdnack, 2001) estimated Average IQ (score between 90 and 110). Participants were 
excluded if they had a history of ABI or other neurological condition. All spoke English as a 
first language and had been educated in an English-speaking, Western culture.  
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Measures 
SPANS 
As described, the SPANS is a brief but comprehensive neuropsychological test battery 
designed to assess cognitive abilities following ABI. It is composed of 33 subtests that make 
up seven indices: Orientation (ORI), Attention/Concentration (ACI), Memory/Learning 
(MLI), Language (LAI), Visual-Motor Performance (VPI), Processing Speed (PSI), and 
Conceptual Flexibility (CFI) (see Appendix C for list of subtests/indices). There are two 
parallel versions of the test, designed to be equivalent and to minimise practice effects. The 
test manual (Burgess, 2013) reported at least adequate internal consistencies (Cronbach’s α ≥ 
.7; Kline, 1999) for the parallel versions and clinical/control groups combined. Despite high 
correlations between the index scores, suggesting they measure a shared ability, there 
remained unshared variance of at least 38.4%, implying that the tests also tap distinct 
abilities. The manual also reported adequate to excellent test re-test correlations between 
forms A and B, supporting the equivalency of the parallel versions, and an excellent inter-
rater reliability of .95 for the Figure Copy subtest (the subtest with the greatest degree of 
subjectivity in scoring procedures). Convergent and divergent validity is supported by large 
(≥ .5: Cohen, 1988) correlations with other theoretically similar neuropsychological tests and 
lower or no correlations with theoretically dissimilar neuropsychological tests and unrelated 
measures. Analysis of variance (ANOVA) demonstrated that the SPANS indices 
differentiated between patients with ABI less than one year previously, patients with long-
term neurological conditions, and healthy controls. Finally, the LAI and VPI evidenced 
capacity to differentiate between left and right hemisphere damage. 
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WTAR 
The WTAR (The Psychological Corporation, 2001) is a reading test that enables prediction of 
pre-morbid intellectual functioning. It is composed of a list of 50 words with irregular 
pronunciations and has been shown to be valid for use with a traumatic brain injury 
population (Green et al., 2008). It was employed in order to include only healthy control 
participants with an estimated average IQ. 
 
Design and procedure 
This was a retrospective study applying psychometric methods to archival data collected by 
Burgess (2013) in order to evaluate the reliability and validity of the SPANS. A combination 
of descriptive, correlational and factor analytic designs were employed in order to address the 
different aims and hypotheses of the study.  
 
During test development, the SPANS was administered as part of routine clinical practice by 
trained clinicians following the manual’s standardised protocol. Efforts were made to keep 
distractions and pauses to a minimum. The SPANS was always the first test administered, in 
some cases followed by the WTAR. Standardised procedures were also followed for healthy 
controls, with randomised allocation of form. Further details can be seen in the test manual 
(Burgess, 2013). All data were entered in an anonymous format into an IBM SPSS Statistics 
database, which was then accessed by the author of the current study.  
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Quality assurance checks 
The database was thoroughly scrutinised by the author to check for errors, which when found 
were resolved by referring to the original paper documentation. All analyses were checked by 
a statistician.  
 
Ethical considerations 
Ethical approval for the original data collection was granted by the Research Ethics 
Committee (see Appendix D). This specified that data could be accessed by other researchers 
with the permission of the original research lead, Dr Burgess. The University Research 
Governance Manager was fully informed of the protocol for the current study (Appendix E). 
All data accessed by the author were fully anonymised. Participants were given a website 
address where they could access information about the study and the results (Appendix F).  
 
Data analysis 
Descriptive statistics of means, standard deviations and ranges for all subtests/indices 
according to group and form is provided in Appendix G. Regarding reliability and validity 
analyses, Cronbach’s α was used to assess the internal consistency of six of the SPANS index 
scales for each participant group and form. Spearman-Brown Prediction formula was used to 
assess reliability of the CFI as this is recommended for scales containing only two subtests 
(Eisinga, Grotenhuis, & Pelzer, 2012). To evaluate the discriminative validity, receiver 
operating characteristic (ROC) curves and classification accuracy statistics were calculated. 
Construct validity was assessed through exploratory factor analysis (EFA). Further details of 
these are provided in the relevant results section. 
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Results: 
1) Reliability: Internal consistency  
The internal consistency of each of the index scores was assessed by calculating Cronbach’s 
α coefficients (or Spearman-Brown formula for CFI) for each participant group separately, a 
combined clinical group, and for the whole sample. Calculations were also made for each 
form separately and combined. The results are presented in Table 3 below, which also 
includes the results reported in the SPANS test manual for comparison. George and Mallery 
(2003) suggested the following guidelines for interpreting Cronbach’s α: “≥.9 – Excellent, 
≥.8 – Good, ≥.7 – Acceptable, ≥.6 – Questionable, ≥.5 – Poor, and <.5 – Unacceptable” (p. 
231). 
 
Table 3: Internal consistency of the SPANS index scores by group and form 
Index ABI LTNC Controls 
Form Both 
n= 61 
A 
n= 49 
B 
n= 12 
Both 
n= 35 
A 
n= 28 
B 
n= 7 
Both 
n= 122 
A 
n= 61 
B 
n= 61 
ORI .766 .761 .773 .771 .780 .720 .282  -.075 .326 
ACI .824 .792 .851 .783 .793 .731 .423 .476 .277 
MLI .894 .893 .835 .827 .760 .920 .669 .609 .744 
LAI .865 .851 .827 .735 .618 .902 .429 .314 .481 
VPI .875 .860 .879 .813 .826 .749 .391 .093 .574 
PSI .834 .768 .886 .859 .875 .778 .314 .248 .378 
CFI .752 .792 .582 .550 .542 .809 .497 .284 .624 
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As Table 3 shows, internal consistency coefficients were all adequate to excellent for the 
sample as a whole, regardless of form. The MLI, LAI and VPI demonstrated the highest α’s, 
whilst CFI and ORI showed the lowest α’s (but still at or approaching excellence). Looking at 
the clinical groups separately, internal consistencies were all adequate to excellent within the 
ABI group with the exception of the CFI form B. Within the LTNC group, all α’s were 
adequate to excellent with the exception of CFI form A/forms combined, which was poor, 
and LAI form A, which was questionable. However, within the healthy control group internal 
consistencies are poor for all bar the MLI.  
 
 
 
 
Index ABI & LTNC Combined Whole sample Results from 
Burgess (2013) 
N =  258 
Form Both 
n= 96 
A 
n= 77 
B  
n= 19 
A 
n= 138 
B 
n= 80 
Both 
N= 218 
ORI .769 .770 .754 .803 .807 .804 .785 
ACI .825 .796 .868 .801 .871 .831 .790 
MLI .897 .887 .895 .876 .929 .899 .899 
LAI .856 .829 .861 .839 .894 .866 .858 
VPI .868 .856 .873 .827 .871 .845 .851 
PSI .849 .814 .896 .808 .880 .838 .840 
CFI .757 .750 .745 .778 .821 .796 .728 
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2) Discriminant validity: ROC curve analysis and classification statistics 
Neurological condition vs. healthy controls 
The ability of the SPANS to discriminate between healthy control participants and those with 
a neurological condition (ABI and LTNC groups combined) was examined through ROC 
analysis and calculation of classification statistics for each form separately and combined. 
ROC curves provide a complete measure of accuracy by plotting discriminative ability (true 
positive rate by false positive rate) across the whole spectrum of potential cut-offs (Kumar & 
Indrayan, 2011). Initially, ROC curves were calculated separately for each index scale and 
their corresponding subtests to establish whether the index scores were a better discriminator 
than the individual subtests. Only letter-number coding (LNC) outperformed its 
corresponding index scales (VPI and PSI) therefore only indices and this subtest are reported 
from hereon in. The ROC curves can be seen in Figures 1 - 3 and information relating to area 
under the curve (AUC) is in Table 4. AUC provides an overall measure of discrimination, 
with a score of one (1.0) representing perfect discrimination. Hosmer and Lemeshow (2000) 
suggest an AUC of ≥.70 is acceptable and ≥.80 is excellent. 
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Figure 1: ROC curve for SPANS indices and LNC subtest for forms combined 
 
Figure 2: ROC curve for SPANS indices and LNC subtest for form A 
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Figure 3: ROC curve for SPANS indices and LNC subtest for form B 
 
As can be seen in Figures 1 - 3, the curves of all scales are above the diagonal ‘line of no 
information’ suggesting using the scale is better than guessing. LNC is the closest to the top 
left corner ‘perfect’ axis. This information is supported quantitatively (as shown in Table 4) 
by highly significant (p<.001) AUCs most of which approach or exceed excellence. 
 
 
 
 
 
 
Evaluation of the SPANS 
 
20 
 
Table 4: Area under the curve statistics for SPANS indices and LNC subtest 
Index/ 
Subtest  Form AUC 
Std. 
Error Significance 
95% Confidence Interval 
Lower Bound Upper Bound 
LNC Both .917 .021 .000 .877 .958 
 A .902 .027 .000 .850 .955 
 B .971 .017 .000 .925 1.000 
ORI Both .797 .033 .000 .733 .861 
 A .822 .036 .000 .751 .892 
 B .809 .072 .000 .668 .950 
ACI Both .801 .031 .000 .741 .862 
 A .763 .040 .000 .685 .841 
 B .868 .054 .000 .762 .973 
LAI Both .810 .029 .000 .753 .867 
 A .835 .034 .000 .769 .901 
 B .847 .062 .000 .727 .968 
MLI Both .797 .031 .000 .736 .858 
 A .739 .042 .000 .657 .822 
 B .912 .037 .000 .840 .983 
VPI  Both .853 .029 .000 .796 .909 
 A .836 .036 .000 .765 .907 
 B .937 .027 .000 .884 .990 
PSI Both .881 .025 .000 .832 .930 
 A .862 .032 .000 .800 .924 
 B .954 .024 .000 .906 1.000 
CFI Both .785 .033 .000 .721 .849 
 A .798 .037 .000 .724 .871 
 B .804 .064 .000 .679 .929 
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Youden’s Index (max: sensitivity + specificity – 1: Youden, 1950) was used to calculate the 
optimal cut-off score for each index according to statistical criteria. However, Lincoln, 
Nicholl and Flannaghan (2003) suggested that in clinical practice, adequate diagnostic 
measures should have a sensitivity and specificity greater than 80% and 60% respectively. 
Therefore cut-offs were chosen that had the highest Youden’s Index and were closest to 
Lincoln and colleagues’ (2003) criteria.  Following this classification statistics were 
calculated. Sensitivity (or true positive rate) refers to the proportion of people with an ABI 
correctly identified as such. Specificity (or true negative rate) refers to the proportion of 
healthy controls correctly identified as such. Likelihood ratio positive and negative (LR±) 
refers to the extent to which a test result changes the probability that a condition exists, or put 
another way how many times more likely a person with an ABI is to have a positive or 
negative test result compared to healthy controls. Positive predictive value (PPV) refers to the 
proportion of positive test results that are true positives, whilst negative predictive value 
(NPV) refers to the proportion of negative test results that are true negatives. This 
information is shown in Table 5. 
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Table 5: Classification statistics for SPANS indices and LNC subtest 
 
 
 Form Cut-off 
(Impaired if 
≤) 
Sens Spec LR+ LR- PPV(%) NPV(%) 
LNC Both 10 .89 .83 5.24 0.13 80 91 
 A 10 .88 .82 4.89 0.15 86 84 
 B 9 .90 .87 6.92 0.11 69 96 
ORI Both 21 .71 .76 2.96 0.38 70 77 
 A 21 .70 .87 5.38 0.31 87 69 
 B 21 .74 .79 3.52 0.33 53 91 
ACI Both 41 .72 .69 2.32 0.35 65 76 
 A 41 .70 .64 1.94 0.47 71 63 
 B 41 .79 .74 3.04 0.28 49 92 
LAI Both 50 .79 .64 2.19 0.33 63 80 
 A 50 .79 .74 3.04 0.28 79 73 
 B 46 .74 .98 3.70 0.27 92 92 
MLI Both 60 .79 .62 2.08 0.34 62 79 
 A 60 .78 .56 1.77 0.39 69 67 
 B 58 .84 .79 4 0.20 56 94 
VPI Both 63 .87 .75 3.48 0.17 73 88 
 A 63 .84 .72 3 0.22 79 78 
 B 63 .95 .77 4.13 0.06 57 98 
PSI Both 40 .80 .84 5 0.24 80 84 
 A 40 .81 .82 4.5 0.23 85 77 
 B 41 .90 .84 5.63 0.12 64 96 
CFI Both 26 .70 .72 2.5 0.42 66 75 
 A 26 .69 .77 3 0.40 79 21 
 B 26 .74 .67 2.24 0.39 41 89 
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As can be seen in Table 5, optimum cut-off scores and classification statistics were largely 
similar across the two forms, though form B tended to demonstrate lower PPVs. The LNC, 
PSI and VPI appear to be the most discriminative measures, with sensitivities above .80 and 
specificities above .70. A person with an ABI is 3 - 5 times more likely to obtain a score 
below cut-off on these measures than a healthy individual.  The LAI, CFI, ORI and ACI were 
less good discriminatory measures, but still demonstrated adequate sensitivities mostly above 
.70 and specificities mostly above .60. Form B tended to outperform form A in terms of 
discriminative ability. 
 
Left vs. right hemisphere damage 
ROC curves were employed to assess the ability of the SPANS LAI and VPI to discriminate 
between left (LH) and right (RH) hemisphere damage. It was not possible to evaluate the 
SPANS forms separately due to small sample sizes, therefore forms are combined for the 
following analyses. ROC curves can be seen in Figures 4 and 5 followed by AUC 
information and classification statistics in Tables 6 and 7. 
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Figure 4: ROC curve showing VPI ability to detect RH damage 
 
 Figure 5: ROC curve showing LAI ability to detect LH damage 
 
 
Evaluation of the SPANS 
 
25 
 
The ROC curves show that both VPI and LAI are able to indicate lateralisation above chance 
level, though LAI appears to be a better indicator. Both LAI and VPI significantly (p<.05) 
discriminate between left and right hemisphere damage and the AUC was acceptable for LAI 
and approaching the acceptable range for VPI. 
 
Table 6: AUC information for VPI and LAI 
 AUC Std. Error Significance 
95% Confidence Interval 
Lower Bound Upper Bound 
VPI .663 .078 .048 .510 .817 
LAI .781 .064 .001 .655 .907 
 
 
Table 7: Classification statistics for VPI and LAI 
 
 
 
 
 
 
Table 7 shows the optimal cut-offs for detecting lateralisation. The VPI approached 
acceptable sensitivity and specificity. A person with right hemisphere damage is almost twice 
as likely to score below the cut-off score on the VPI. The LAI demonstrated good specificity 
but lower sensitivity. However, the LR+ shows that a person with left hemisphere damage is 
over four times more likely to score below the cut-off score on the LAI. A score below cut-
 Cut-off 
(if ≤) 
Sens Spec LR+ LR- PPV(%) NPV(%) 
VPI  54 .75 .58 1.79 0.43 62 72 
LAI  42 .69 .83 4.06 0.37 81 71 
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off on the VPI indicates a 62% chance of right hemisphere damage, whilst a score below cut-
off on the LAI indicates an 81% chance of having left hemisphere damage. 
 
3) Exploratory Factor Analysis (EFA) 
Factor analysis is a technique which reduces a large set of variables into a smaller set of 
variables seen to represent the underlying latent factors within a dataset. EFA was run on the 
entire sample and forms combined (N = 218), as theoretically the underlying constructs 
should not differ between clinical and control groups or between forms. Principal axis 
factoring was chosen over principal component analysis as the former method is favoured 
when there are pre-existing theoretical grounds for particular underlying constructs, whereas 
principal component analysis provides a descriptive empirical summary of a dataset 
(Tabachnick & Fidell, 2001). Principal axis factoring is also argued to be more accurate 
(Cliff, 1987) and to generalise better to confirmatory factor analysis (Floyd & Widaman, 
1995). This is because it excludes error and unique variance and analyses covariance 
(communalities) only (Tabachnick & Fidell, 2001). Oblique rotation was chosen as this is the 
preferred method when theoretically one would expect factors to be related (Field, 2009).  
 
Comrey and Lee (1992) suggest that a sample size of 200 is fair and the results of the Kaiser-
Meyer-Olkin test, a statistical measure of the adequacy of sample size, was considered 
“superb” at .935 (Hutcheson & Sofroniou, 1999; cited in Field,2009). Bartlett’s test of 
sphericity, a measure of whether overall correlations are large enough to indicate underlying 
factors, was also significant: χ² (528) = 5684.12, p<.001. Visual screening of the correlation 
matrix for all items showed that no items correlated at or above .90, implying no concerns 
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regarding multicollinearity or singularity (overly high or perfect correlations between 
variables, implying redundancy of items) (Field, 2009). Therefore EFA was deemed 
appropriate. 
 
An initial unconstrained principal axis factoring indicated five factors with initial 
Eigenvalues greater than 1 (Kaiser’s criterion: Kaiser, 1960). The scree plot was slightly 
ambiguous, with points of inflexion that would justify retaining both three and five factors. 
The initial five-factor solution was examined for items with a loading ≥ .4 (as recommended 
by Stevens, 2002). Items crossloading onto two factors at .32 or higher and with less than .2 
magnitude difference were deleted (as recommended by Tabachnick & Fidell, 2001). This 
resulted in the deletion of nine items and left one factor composed of only two items, 
generally deemed “weak and unstable” (Costello & Osborne, 2005, p.5).  
 
Next, an analysis was run forcing four factors to be retained. Following the above criteria, 
three items were deleted due to cross-loadings and two factors were left with only three 
items. Finally, an analysis was run forcing three factors to be retained, due to examination of 
the scree plot indicating that this was another point of inflexion. This resulted in eight items 
being deleted due to cross-loadings or loadings below .4: Orientation to Time and Place, 
Figures Recognition, Sustained and Divided Listening I and II, Counting Backwards, 
Monetary Calculations, and List Learning. This three-factor solution was retained as the 
resulting factors each had more than five strongly loading (>.5) items, indicating a solid 
factor (Costello & Osborne, 2005). The factors were interpretable theoretically, and together 
they accounted for 56.23% of the total variance, deemed reasonable (Streiner, 1994). Table 8 
shows the factor loadings after rotation. 
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Table 8: Summary of factor loadings after rotation for final 3-factor solution 
 
Factor 
1 2 3 
Facial Expressions .668     
Spatial Decision .631     
3 and 1 Concept Test .624     
Time Estimation .600     
Figures Copy .593     
Orientation to Time .535   -.386 
Object Recognition .531     
Letter-Number Coding  .514 .303   
Unusual Views .479     
Figures Recognition .478   -.422 
Sustained and Divided Listening I .396 .308   
Orientation to Place .307     
Following Directions   .782   
Yes/No Questions   .774   
Naming   .730   
Reading    .719   
Writing Sentences   .671   
Repetition   .652   
Similarities   .616   
Digit Span Forward   .513   
Counting Backwards .362 .495   
Digit Span Backward   .462   
Orientation to Condition   .421   
Monetary Calculations .372 .396   
Sustained and Divided Listening II .326 .361   
List Recall     -.874 
Object Recall     -.845 
List Recognition     -.794 
Figures Recall     -.719 
Word-Symbol Paired Associates     -.671 
Orientation to Prime Minister/President     -.522 
List Learning   .461 -.509 
Orientation to Person     -.505 
 
Extraction Method: Principal Axis Factoring. Rotation Method: Oblimin with Kaiser 
Normalization. Loadings < .3 are suppressed. Bold loadings represent items to be 
included in factor. 
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The final EFA solution resulted in 25 subtests making up three factors which account for 
56% of the total variance. The first factor appeared to relate predominantly to visual-motor 
performance and accounted for 47% of the variance. The second factor appeared to relate 
predominantly to language abilities and accounted for 5% of the variance. The third factor 
appeared to relate to memory and accounted for 4% of the variance. Examination of the 
factor correlation matrix showed moderate to high correlations between all factors, with 
factor three showing the highest correlations with factor one (r =  .59) and factor two (r =  
.60). 
 
Internal reliability of factors 
Cronbach’s α were calculated to check the internal consistency and reliability of the three 
factors determined through EFA. All factors demonstrated good reliability with Cronbach’s α 
≥ .8 (range: .836 - .886). All items demonstrated high item-to-total correlations and 
contributed to the factor, therefore no further items needed to be deleted. 
 
Discussion  
Reliability and validity of the SPANS 
The current study provides further evidence of the validity of the SPANS for the assessment 
of cognitive function in people with an ABI. In support of the first hypothesis, internal 
reliability was shown to be mostly adequate to excellent within the clinical groups both 
separately and  combined for all indices, irrespective of form.  In keeping with the second 
hypothesis ROC curves showed that each index and the LNC subtest (irrespective of form) 
were able to significantly discriminate between healthy controls and patients with a 
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neurological condition, with all AUCs at acceptable or excellent levels. Furthermore, in 
keeping with previous studies (e.g. Capruso & Levin, 1992) classification statistics showed 
that the indices with more ‘ability-focused’ tests (Larrabee, 2008)such as LNC, VPI and PSI 
were the best discriminators, with all sensitivities and specificities above Lincoln and 
colleagues’ (2003) criteria. The LAI and VPI demonstrated significant discriminative ability 
for lateralisation. Scores below optimal cut-offs on the LAI and VPI was indicative of left 
and right hemisphere damage respectively, in keeping with previous evidence of lateralisation 
of language and visual skills (Kolb & Whishaw, 2003). Regarding the third aim and 
hypothesis of the study, partial support for the construct validity of the SPANS was 
demonstrated by EFA which resulted in three theoretically meaningful factors composed of 
25 subtests explaining 56% of the total variance, all with good internal reliabilities. 
 
Within the healthy control group, Cronbach’s α were predominantly poor. Examination of 
frequency distributions and subtest inter-correlations within the healthy control sample 
showed that most items were negatively skewed, had limited or zero variance and few 
significant strong correlations, which all tend to deflate Cronbach’s α (Cortina, 1993). Other 
authors have similarly reported difficulties calculating internal consistency for healthy 
subjects due to limited variability (e.g. Bullard et al., 2004). The SPANS was designed to be 
challenging but passable by healthy subjects (Burgess, 2013), hence the negative skew and 
limited variability. Alternatively, the low internal consistencies could mean that the index 
scores are not tapping into distinct cognitive constructs and that therefore the test is 
measuring something different in healthy participants compared to clinical. Research has 
shown that using cognitive strategies (e.g. visualisation) can impact test performance (Ball et 
al., 2002). It is plausible that healthy participants, with their intact cognitive abilities, 
employed a broader range of strategies to solve test problems and that therefore each test item 
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may be measuring abilities other than what they purport to. However, it seems more likely 
that the results are a spurious effect of the limited variance. As the SPANS was designed to 
identify cognitive impairment in people with an ABI rather than to assess normal variability 
in cognitive skills in the general population, it is more important that it demonstrates good 
reliability within the clinical groups. 
 
The ROC curves and classification statistics offer initial support for the discriminative 
validity of the SPANS and provide clinicians with information regarding its diagnostic 
accuracy. Though performance of the two forms was largely similar, there were discrepancies 
between forms on the LAI and MLI such that form B demonstrated better specificity and 
LR+ compared to form A. This begs the question of whether the parallel versions are truly 
equivalent, or whether this is a spurious effect of sampling differences.  It is difficult to 
attribute any observed differences between forms on the LAI as being due to non-equivalence 
as this index has only one subtest which varies between forms (Naming). Therefore sampling 
differences may be responsible. A smaller proportion of participants administered form B had 
left hemisphere damage and therefore may have had fewer focal language deficits. Regarding 
the MLI, all subtests vary between forms and therefore the observed differences in 
classification accuracy may reflect real differences between the tests. This may be the case 
despite the great care that was taken to ensure equivalence (see Burgess, 2013 for full details) 
during the design and development stages of the SPANS. However, sampling differences 
again cannot be ruled out. 
 
The reported structure of the SPANS is five distinct and two overlapping index scales 
(Burgess, 2013). This structure was only partially supported by the results of the EFA in the 
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current study. The most interpretable and strongest solution indicated three factors: language, 
visual-performance and memory/learning. These factors corresponded largely to LAI, VPI 
and MLI indices, with a few differences. Specifically, the visual-performance factor excludes 
the Figure Recognition subtest as this loaded equally well onto the memory factor. 
Theoretically this makes sense as the task clearly involves both visual processing and 
encoding. The visual-performance factor also included the Time Estimation subtest. Other 
studies have shown impairments in time estimation to be linked to damage in temporo-
parietal regions of the brain (Barabassy, Beinhoff, & Riepe, 2007), which are also strongly 
associated with visuospatial processing and knowledge of numbers (Kosslyn, 2007; 
Blakemore & Frith, 2005). All subtests from the LAI demonstrated the strongest loadings 
onto the language factor. Weaker loadings came from Digit Span and Orientation to 
Condition subtests, which may be due to the reliance on language in order to understand the 
instructions/question and produce a verbal answer with adequate sophistication. Similarly, the 
strongest loadings onto the memory factor came from the original MLI subtests, with 
additional weaker loadings from the Orientation to Prime Minister/President and Person 
subtests. It could be argued that these both rely on retrieval from long-term memory systems. 
 
Factor analytic studies of other neuropsychological assessment batteries have similarly not 
always supported the reported test structure. As mentioned in the introduction, a principal 
components analysis of the RBANS resulted in a two-factor solution, as opposed to the five 
factor test structure purported by the test (Wilde, 2006). Cognitive constructs of orientation, 
attention, concentration, processing speed and executive function appear to be the hardest to 
assess in isolation, perhaps as these are more shared cognitive processes on which successful 
completion of any task will rely. For example, a person’s ability to attend to task will clearly 
affect performance in all domains (Hodges, 1999). Furthermore as noted in the introduction 
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attention is not a unitary concept (Sohlberg & Mateer, 1989), nor are executive functions 
(Poulin, Korner-Bitensky, & Dawson, 2013). It is therefore perhaps not surprising that these 
do not emerge as independent factors in EFA. 
 
The SPANS is one of only a few brief neuropsychological assessment batteries that has been 
designed specifically for the purpose of assessing cognitive function in patients with an ABI. 
It was developed following extensive review of the theoretical and empirical literature, as 
summarised in the introduction. In comparison to similar existing batteries (RBANS and 
NAB-SM), the SPANS demonstrated better internal reliabilities across all its index scores for 
the clinical group (see McKay et al., 2007; Zgaljardic & Temple, 2010). Classification 
statistics are not available for the NAB-SM, and the SPANS indices have higher specificities 
(though generally lower specificities) compared to the RBANS (see McKay et al., 2008). 
Similarly, there have not been any factor analytic studies of the NAB-SM, and as mentioned 
a principal component analysis of the RBANS did not support its five-factor structure (Wilde, 
2006). Therefore, the current study provides preliminary evidence for the design aim of the 
SPANS in addressing the psychometric limitations of existing brief neuropsychological 
batteries and appears to be a reliable and valid tool for the assessment of cognitive function in 
people with an ABI.  
 
Limitations of the study 
There are a number of limitations to the current study which impact on the conclusions that 
can be drawn. Due to the archival and retrospective nature of the study, there was a relative 
lack of control over sampling design and composition of participants. Participants were 
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recruited from a relatively homogeneous area geographically and so may not generalise to 
other regions. Sampling was non-consecutive introducing the possibility of bias in the data 
(e.g. the absence of more severely impaired participants). The data from participants who 
were unable to fully complete the SPANS was excluded (as is the case with most 
neuropsychological batteries), meaning the current sample is not representative of all people 
presenting to neurorehabilitation services and may reflect those with relatively less severe 
injuries. The clinical group is heterogeneous in terms of onset, cause, severity and location of 
injury. Sample sizes are relatively small, particularly for SPANS form B and the lack of 
systematic control over sampling procedures meant that groups were not necessarily 
comparable on all variables. The above factors all limit the generalizability of the results, a 
common issue in brain injury research (Car-Blanchard, 2004). 
 
Although establishing the equivalency of the parallel versions of the SPANS was not a 
specific aim of the current study, attempts were made to compare the forms throughout the 
analyses to improve control. This was not always possible or valid due to sample sizes (e.g. 
in evaluating discriminative validity for lateralisation) and interpretations of differences are 
complicated by the lack of control over sampling procedures and therefore potential 
differences between groups. For the EFA, the entire sample was analysed as a whole in order 
to have a large enough sample size, but some authors argue that underlying factor structure 
needs to be determined in the group for which the test is designed independently, as sample 
composition can impact on the results (Delis, Jacobsen, Bondi, Hamilton, & Salmon, 2003).  
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Clinical/theoretical implications 
Neuropsychological assessment has a critical role to play in brain injury rehabilitation in 
terms of assessing a patient’s cognitive strengths and weaknesses, learning potential, capacity 
to make complex decisions, and predict care needs and functional outcomes (Harvey, 2012). 
There has been a gap for clinicians for brief but comprehensive cognitive assessments with 
strong theoretical and empirical underpinning to their development and sound psychometric 
properties. The current study provides preliminary support for the clinical utility, reliability 
and validity of the SPANS for the assessment of cognitive impairment in patients with an 
ABI or other neurological conditions. The study also strengthens previous research that has 
shown ‘ability-focused’ tests to discriminate between healthy controls and patients with a 
neurological condition better than semantic knowledge tests (e.g. Larrabee, 2008).  
 
Future research directions 
In order to provide further validation of the clinical utility, reliability and validity of the 
SPANS and to determine generalizability of the current results, it would be helpful to repeat 
the current analyses in an independent sample. Further research assessing the predictive 
validity of the SPANS, e.g. of future cognitive status, return to work, or community 
integration would also be beneficial. In order to ascertain the equivalence of the parallel 
forms, an experimental design could be employed using either repeated measures over a fixed 
time period in a counterbalanced order, or using a carefully matched independent groups 
design. This would help to calculate potential practice effects in order to be able measure 
change due to treatment effects more precisely. With a larger, independent sample 
confirmatory factor analysis could be conducted to test the seven or five factor structure of 
the test, or the three factor structure produced in the current study. 
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Although the SPANS was designed primarily for use with working age ABI populations, it 
has the potential to expand into other groups, such as children and adolescents, older adults, 
other clinical conditions such as dementia, and other settings such as forensic. Further 
research is needed to assess its suitability and psychometric properties in these areas.  
 
Conclusions 
Assessing cognition is an important role for clinical psychologists in neurorehabilitation 
services but there is a lack of theoretically and psychometrically valid brief 
neuropsychological assessment batteries available. The SPANS was designed to meet this 
need. The results of the current study demonstrated that the SPANS had high internal 
reliability when administered to patients with an ABI or other neurological condition. It also 
demonstrated good discriminative ability between healthy and clinical patients and detected 
left or right hemisphere damage with some confidence. The visual performance, language and 
memory indices were strongly supported by findings from EFA, suggesting that these are 
valid and reliable constructs and map to some degree the a priori structure of the measure. 
Overall, the SPANS appears to at least match and even outperform similar existing measures 
and meet its design aims of being a reliable and valid tool for the assessment of cognitive 
impairment in patients with an ABI. 
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What research skills have you learned and what research abilities have you developed 
from undertaking this project and what do you think you need to learn further? 
The whole process of developing a research proposal through extensive reading of the wider 
literature, formulating research questions and hypotheses, exploring different potential 
research designs and methodologies and then submitting a proposal for peer review was a 
relatively novel experience for me, not having come into training from a research 
background. This part of the research process helped me to develop skills in concisely 
summarising existing theoretical and empirical literature in order to provide a clear rationale 
for the research aims and hypotheses, and also in describing and justifying research designs 
and methodology in a clear and explicable manner. Having my initial project turned down at 
the second ethics review really highlighted to me the importance of this stage of the research 
process and the necessity of being able to provide an account of a project that can be readily 
understood in lay terms and that has clear, positive, clinical implications. Though it felt very 
difficult at the time, this occurrence enabled me to reflect on the ethical issues with 
conducting basic/pure research compared to more applied research (Roll-Hansen, 2009), 
particularly when involving human participants. It also highlighted the importance of 
involving service users and other stakeholders in the design stages of research in order to 
ensure that research is acceptable to the people it most concerns. Thus for my second research 
proposal I took greater care in ensuring that the clinical implications were very apparent. 
 
Conducting secondary analyses of existing datasets has some obvious examples in terms of 
removing the difficulties inherent with recruitment and data collection and possible 
confounds of experimenter bias (Shultz, Hoffman, & Reiter-Palmon, 2005). However, the 
challenges involved with this type of research were perhaps greater than I had originally 
anticipated. The majority of teaching received during training is tailored to gathering and 
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analysing new data, therefore there was little guidance available as to how to go about the 
process or what pitfalls to look out for. For example, following my review of the literature, I 
developed numerous potential research questions and designs, many of which turned out not 
to be possible with the existing dataset due to issues with the sampling procedures, sample 
size, or research design meaning that assumptions for certain statistical procedures could not 
be met. Whilst this was a time consuming and at times frustrating process, it also meant that I 
developed substantial knowledge about psychometric theory and methods, statistical 
analyses, and became much more proficient in exploring and managing datasets. 
 
Receiver operating characteristic curves and classification statistics are a fundamental tool in 
clinical practice for evaluating the diagnostic or classification accuracy of a clinical measure 
(Zweig & Campbell, 1993). Hence gaining knowledge and understanding of and ability to 
apply these procedures has been an invaluable and challenging learning experience. I was 
able to be largely self-directive and autonomous in my approach to this learning, as this was 
not an area that my supervisors were familiar with themselves. This was useful in terms of 
increasing my confidence in learning and applying novel statistical procedures, but also in 
enabling me to feel a greater sense of ownership over the research project, despite not having 
collected the data myself. In order to conduct the exploratory factor analysis, I gratefully 
sought out consultation from a statistician. Having this expertise was essential to guide me on 
the numerous complex decisions required for conducting factor analysis, such as which type 
of factor analysis to use, how many factors to retain, which type of rotation to employ, how to 
interpret the factors, how to establish validity of the analysis and so forth. Having my 
decision-making process validated by someone with much greater knowledge and expertise 
helped me feel assured that the steps I had chosen were justified. In future I would feel more 
able to conduct this kind of analyses independently, and quantitative research more generally. 
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An area of research I feel I need further development and learning in would be in qualitative 
methods, as this is not something I was able to employ within the current study.   
 
 
If you were able to do this project again, what would you do differently and why? 
Ideally, given significantly more time, I would have liked to have been able to collect 
additional data in order to increase sample sizes but also to attempt to address some of the 
variability between-groups on some of the variables, particularly for those who were 
administered form B. Alternatively, amending the sampling procedures so that equal numbers 
of form A and form B were administered in a randomised but stratified manner, according to 
the key demographic and injury-related variables, would have enabled further analyses, e.g. 
of form equivalency, to be undertaken and strengthened the resulting conclusions. Collecting 
further data would also have given me the advantage of learning how to administer the test 
and expediting the process of familiarising myself with the test materials and the nature of 
each subtest, which was important for interpreting the results in light of the 
neuropsychological theory and research underpinning the choice of subtest. Unfortunately, 
due to the delay in commencing this project it was not possible to include further data 
collection with the proposal as this would have been subject to additional ethics review, as 
well as the additional time in recruitment. 
 
An original aim of the project was to look at test form equivalency and quantify any potential 
practice effects using the repeated measures data. Unfortunately, following exploration of the 
dataset and gathering further information about the sampling procedures and study design, it 
became apparent that it would not be possible to draw any firm conclusions from the results. 
Feeding this back to my supervisor felt quite sensitive as I did not wish to appear critical or 
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unappreciative of the extensive amount of time and effort that had been spent on developing 
the measure and collecting the data; however I also did not wish to conduct analyses that I 
felt were not valid from a more stringent scientific/psychometric point of view. Again, 
adapting sampling procedures or collecting additional data could have resolved this issue. To 
enhance interpretation of the differences between the forms, I could have calculated 
confidence intervals for sensitivity and specificity figures. This is not something I had seen 
reported in other published studies and unfortunately time limitations did not allow me to do 
this. 
 
As a consequence of doing this study, would you do anything differently in regards to 
making clinical recommendations or changing clinical practice and why? 
The conclusions from the review of the extant literature clearly identified that there is a need 
in neuro-rehabilitation services for a brief but comprehensive, easy to administer, 
psychometrically reliable and valid neuropsychological tool for assessing cognitive function 
in people with an acquired brain injury. The current study provides preliminary support for 
the reliability, discriminative validity and factor structure of the Short Parallel Assessments 
of Neuropsychological Status (SPANS). Therefore, as a consequence of doing this study I 
would recommend the use of the SPANS in neuro-rehabilitation services in order to ascertain 
patients’ level of cognitive functioning and track change over time. However, that said it 
would also be important for clinicians to continue to keep abreast of further research 
conducted with the SPANS as there is still a need for further validation studies. 
 
Clinical psychology training and current models of health care emphasise the importance of 
being a scientist practitioner (Barlow, Hayes, & Nelson, 1984), part of which requires using 
reliable and valid assessment tools/outcome measures and promoting evidenced-based 
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practice. However, I had not fully considered the issues, from a psychometric theory 
perspective, of using an amalgam of different neuropsychological tests that have not been co-
normed together. My experience of conducting neuropsychological assessments clinically 
both prior to and on placement, as well as my understanding from reading the literature (e.g. 
Kosaka, 2006), is that this is the most common approach taken by clinicians when carrying 
out neuropsychological assessments. As a result of completing this study, I would 
recommend that clinicians use a co-normed battery wherever possible. Where this is not 
possible, I would recommend that clinicians ensure that they are familiar with the normative 
data for the tests they are using and think about issues to do with comparability of norms, risk 
of false positive/negative results due to random error, and normal variation in abilities in the 
target population (for further critique of flexible batteries see Russell, Russell, & Hill, 2005).  
 
My understanding of diagnostic/classification statistics (e.g. sensitivity and specificity) has 
enhanced as a result of doing this study and this has made me more aware of the risks and 
likelihood ratios of making false positive or false negative conclusions from tests. The 
importance of this will vary considerably depending on what a test is being used for and the 
consequences of having or not having a diagnosis. Arguably, within neurorehabilitation 
services, it may be better to falsely claim that someone has a cognitive impairment and allow 
them access to services and support rather than for cognitive impairment to go undetected and 
for a person to suffer the consequences in isolation. I will certainly pay more attention to this 
area when using standardised measures of any sort in clinical practice. 
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If you were to undertake further research is this area what would that research project 
seek to answer and how would you go about doing it? 
A key area of research that appears to be relatively lacking in the broader field of 
neuropsychological assessment is evidence for how the results of neuropsychological 
assessment inform treatment planning and delivery and the impact of this on patient 
outcomes both short and long-term. This is a difficult area to study as it would not be possible 
to conduct a randomised controlled trial with some patients having a neuropsychological 
assessment and others not due to ethical issues of denying people an intervention predicted to 
be beneficial to their recovery (Temple & Ellenberg, 2000). An alternative possibility would 
be to compare two different measures, such as the SPANS and an equivalent test, on the 
results and recommendations of the assessment and subsequent patient outcomes, using an 
experimental or quasi-experimental design. A third possibility would be to conduct a 
retrospective study comparing neuro-rehabilitation patients who have or have not received a 
neuropsychological assessment in terms of their rehabilitation programs and outcomes. 
However, this approach would be limited by possible confounds between the samples as 
people who are referred for neuropsychological assessment are likely to have different 
presentations from those who are not. 
 
In terms of further research relating more specifically to the SPANS, establishing the 
equivalence of the parallel versions of the test and quantifying potential practice effects 
appears essential, given the observed differences in performance in the current study, in order 
for clinicians to have confidence in the SPANS’ ability to track recovery over time. To do 
this, I would recruit people with long-term and stable neurological conditions, in order to 
have enough variability in performance within the sample whilst not expecting further 
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recovery/decline in cognitive function. I would employ an experimental repeated measures 
design, administering form A and form B in a counterbalanced order at a set time interval 
apart, e.g. one week. Ideally, time between testing could be a moderating variable in order to 
see whether practice effects change time. Conducting research with people who have 
neurological conditions is challenging due to issues around prevalence, recruitment, informed 
consent, and physical or cognitive ability to participate. Therefore I acknowledge that to 
conduct this research would require extensive resources and time. To make it more feasible, it 
would be best if it could be conducted in a service that was already using the SPANS as part 
of standard clinical practice, in order to not add an additional burden onto a clinical team. 
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Appendix A: Literature Search 
 
All databases searched from their establishment to March 2013 
 
Ovid Medline search strategy (MeSH terms in italics): 
 
Brain Injuries or brain injuries or head injuries or Craniocerebral Trauma  or Brain Ischemia  
or Stroke or Brain Damage, Chronic or Hypoxia-Ischemia, Brain or brain damage 
AND 
Neuropsychological Tests or neuropsychological assessment or cognitive assessment or 
screening tests 
AND 
Psychometrics or psychometrics or Reproducibility of Results or reliability or validity 
LIMIT: humans and English language. 
 
Result: 1274 articles 
 
PsychINFO search strategy (subject headings in italics): 
 
Brain injuries or Traumatic Brain Injuries or head injuries or Head Injuries or brain damage 
or Brain damage or Cognitive Impairment or Cerebrovascular Accidents 
AND 
Neuropsychological assessment or Neuropsychological Assessment or cognitive assessment 
or Cognitive Assessment or screening tests or Screening Tests 
AND 
Psychometrics or psychometrics or Test Validity or validity or Test Reliability or reliability 
LIMIT: humans, English language and peer reviewed journals. 
 
Result: 980 articles 
 
EBM Reviews search strategy. 
Neuropsychological assessment or cognitive assessment or screening tests 
AND 
Psychometrics or reliability or validity 
AND 
Brain injury or head injury or brain damage. 
 
Result: 4 articles – none relevant. 
 
Total elicited studies: 2,258 
 
This systematic search was supplemented by an unsystematic search on Google using 
individual test names and reference to Lezak (2004) in order to gather further information 
about the tests as needed. 
 
Neuropsychological tests were included if: 1) they were designed to assess for cognitive 
impairment in multiple domains and separate scores for each domain could be calculated; 2) 
were performance-based measures given direct to patients; 3) could be administered in one 
hour or less; and 4) had been published in English. Studies involving individual standardised 
tests, flexible batteries, standardised batteries with administration times of over one hour, 
tests which only give a global score, or unpublished tests (e.g. those in development that were 
not accessible) were excluded. 
Appendix A: Literature Search 
 
 
Papers relating to each neuropsychological test were included if: a) the main aim of the study 
was to investigate the psychometric properties (e.g. reliability or validity) of the test; and b) 
participants were predominantly working age (16 – 65 years old), English-speaking, adults 
with an ABI. Studies including older adults were retained if the mean age was less than 65 
years old. Studies conducted solely with children and adolescents or older adults were 
excluded, as were studies with neurodevelopmental (e.g. learning disabilities) or 
neurodegenerative (e.g. dementia syndromes, Parkinson’s disease, Multiple Sclerosis) 
conditions. Physical illnesses with associated cognitive impairments (e.g. HIV) were also 
excluded. 
 
The initial search resulted in 2,258 hits across the databases. Titles and abstracts were 
screened according to the above criteria. In some cases where the required information was 
not clearly stated (e.g. no ages/diagnosis/name of test given), or apparent from the name of 
the journal (e.g. Dementia) the full text was sought. None of these met inclusion criteria. 
Removal of duplicates resulted in 15 papers meeting the inclusion and exclusion criteria. 
Searching the reference lists did not add any papers; nor did a second search on PsychINFO 
using the individual test names combined with “psychometrics”.  
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Ref Aim(s) & Measure(s) Participants Analysis & Results 
Doninger, N. A>, Bode, R. K., 
Heinemann, A. W., & 
Ambrose, C. (2000). Rating 
scale analysis of the 
neurobehavioural cognitive 
status examination. Journal 
of Head Trauma 
Rehabilitation, 15(1), 683-
695. 
Evaluate extent NCSE items 
represent a unidimensional 
construct. 
Investigate appropriateness for 
characterising range of cognitive 
functioning. Explore extent to 
ǁhiĐh iŶdiǀidual’s perforŵaŶĐe 
on domain specific items fit 
expected pattern. 
 
N = 186 community TBI; 140 male, 46 
female; mean age 34 (range 18-60); 
mean education years 12 (range 6-20); 
median injury onset 32 months (range 
1-336 months). 
Rating Scale Analysis (Rasch): 
Several analyses performed to create unidimensional 
measure. Deleting easy and misfitting items improved 
measure without increasing error. 
Calibration of domains could only reliably distinguish 
normal/impaired. 
 
Doninger, N. A., Ehde, D. M., 
Bode, R. K., Knight, K., 
Bombardier, C. H., & 
Heinemann, A. W. (2006). 
Measurement properties of 
the neurobehavioral 
cognitive status examination 
(Cognistat) in traumatic 
brain injury rehabilitation. 
Rehabilitation Psychology, 
51 (4), 281-288. 
Calibrate item responses applying 
various RSA measurement 
strategies to investigate 
Cognistat’s ability to distinguish 
meaningful levels of cognitive 
impairment in 
inpatient/outpatient TBI. 
Investigate appropriateness of 
Cognistat for characterising types 
of cognitive impairment. 
N = 120 TBI inpatients drawn from 
consecutive admissions; 98 male, 22 
female; mean age 37.5 (SD 12.6); 98 
Caucasian, 11 African American; 22 
educated > high school, 50 high 
school, 47 < high school; mean injury 
onset days 29 (SD 29). 
N = 286 community TBI; 230 male, 56 
female; mean age 36 (SD 9.9); 69 
Caucasian, 25 African American; 89 
education > high school, 123 high 
school, 76 < high school; mean injury 
onset days 2,496 (SD 3,168). 
 
Rating Scale Analysis (Rasch): 
Computed calibrations separately for inpatient/community 
groups using entire item, shortened item, and cognitive 
domains. 
Three strata of performance were differentiated despite a 
skewed distribution towards high performance among 
community sample. Elimination of easier items improved the 
instrument without increasing measurement error.  
Memory and verbal reasoning were the most difficult 
domains however analysis indicated significant memory. 
Calibration of domains could only reliably distinguish 2 levels 
(normal/impaired) in inpatient sample. 
Duff, K., Beglinger, L. J., 
Jenks-Kettmann, J. D., & 
Describes the performance of the 
RBANS and other 
Case study 22 year old, left-handed, 
white, single woman with high school 
All scores converted to standardised scores then 
standardised change scores calculated for comparisons. No 
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Bayless, J. D. (2006). Pre- 
and post- right middle 
cerebral artery stroke in a 
young adult: A case study 
examining the sensitivity of 
the repeatable battery for 
the assessment of 
neuropsychological status 
(RBANS). Applied 
Neuropsychology, 13 (3), 
194-200. 
 
 
neuropsychological tests: WAIS-
III, RCFT, WRAT-3, TMT, TOMM, 
BDI-II. 
education referred for cognitive 
assessment in context of history of 
numerous psychiatric admissions for 
self-harm, suicidality and mood 
lability. Diagnosed BPD and dysthymic 
disorder. Baseline IQ 85. 3 weeks after 
admission presented with left 
hemiparesis and dysarthria. MRI 
revealed right frontal embolic stroke. 
significance testing. 
Post-stroke showed decline on Immediate memory index 
(story memory subtest), visuospatial/constructional index 
(figure copy & line orientation subtests), attention index 
(coding subtest, digit span improved). Most change in 
visuospatial/constructional index of RBANS. Performance on 
other neuropsychological tests consistent with RBANS. 
Gaber, T. A-Z. K. (2008). 
Evaluation of the 
AddeŶďrooke’s ĐogŶitiǀe 
eǆaŵiŶatioŶ’s ǀaliditǇ iŶ a 
brain injury rehabilitation 
setting. Brain Injury, 22 (7-
8), 589-593. 
 
Evaluate the practicalities, 
pattern of impairments, and 
establish the sensitivity of the 
ACE-R for TBI 
N = 36 TBI admitted to rehab clinic; 31 
male, 5 female; mean age 37.2 (SD 
14.1); mean education years 11.1 (SD 
2.7); mean injury onset months 22.5 
(SD 12.5) 
Sensitivity 100%/72%/56% (cut offs: 93, 88, 82). 
(Compared to MMSE 53%/36%/11%) 
T-test: Compared to norms published elsewhere, ACE-R total 
and subtest scores significantly more impaired (p<0.001). 
Larson, E., Kirschner, K., 
Bode, R., Heinemann, A., 
Goodman, R. (2005). 
Construct and predictive 
validity of the repeatable 
battery for the assessment 
of neuropsychological status 
Assess 1) convergent/divergent 
validity and 2) predictive validity 
of RBANS. 
Reference tests: TMT; line 
cancellation; EXIT; BDAE; WAIS-R 
vocabulary; RPM; Benton faces; 
Study 1: N = 158 stroke patients; 80 
female, 78 male; mean age 64.27 (SD 
14.45); right hemisphere 49%, left 
hemisphere 44%, bilateral 7%. 
Study 2: N = 36 stroke patients; 19 
female, 17 male; mean age 63.21 (SD 
16.19); right hemisphere 67%, left 
Study ϭ) CoŶvergeŶt/divergeŶt validity: PearsoŶ’s ProduĐt 
moment Bivariate correlations (p<0.001): 
Attention index: not sig correlated with any measures 
attention but was sig correlated with measures of language 
(WAIS-R, BDAE). 
Language index: convergent validity with WAIS-R/BDAE but 
 Appendix B Summary of included studies  
 
in the evaluation of stroke 
patients. Journal of Clinical 
and Experimental 
Neuropsychology 27 (1), 16-
32. 
RBMT. 
Outcome measures: FIM 
motor/cognitive; FAI; CHART 
hemisphere 25%, bilateral 8%. also sig correlates with EXIT/RBMT. 
Visuospatial index: convergent validity with RPM/Benton 
faces but also sig correlations with TMT/line 
cancellation/WAIS-R/RBMT. 
Memory: convergent validity with RBMT but also sig 
correlations with EXIT/BDAE/WAIS-R. 
Controlling for verbal intelligence (WAIS-R) does not affect 
attention index but strengthens convergent validity for other 
indices. 
Study Ϯ) prediĐtive validity: PearsoŶ’s ProduĐt ŵoŵeŶt 
correlations: 
FIM-cog sig correlations with all RBANS scores except 
Attention. 
FAI significant correlation with visuospatial index. 
 
McKay, C., Casey, J. E., 
Wertheimer, J., & 
Fichtenberg, N. L. (2007). 
Reliability and validity of the 
RBANS in a traumatic brain 
injured sample. Archives of 
Clinical Neuropsychology, 
22, 91-98. 
Evaluate the internal reliability of 
the RBANS index scores and 
construct validity of the subtest 
scores. 
Reference tests: CVLT; BVRT; 
MAE; COWAT; WAIS-III digit 
span/coding 
N = 57 consecutive moderate to 
severe TBI patients referred to 
neurorehab outpatient clinic; 35 male, 
22 female; mean age 35.72 (SD 14.62); 
mean education years 12.58 (SD 1.61); 
40 Caucasian, 17 African American; 
mean injury onset months 84.88 (SD 
101.15). 
Internal consistency: Chronbach alphas: 
Immediate memory: 0.75; Visuospatial: 0.76; Language 0.33; 
Attention: 0.16; Delayed memory: 0.77; Total: 0.84. 
Convergent validity: Correlation coefficients: 
Significant correlations with tests measuring similar 
constructs. Range r=0.381 (List recog & CVLT recog) to 
r=0.83 (Coding & WAIS-III coding). 
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McKay, C., Wertheimer, J. C., 
Fichtenberg, N. L., & Casey, 
J. E. (2008). The repeatable 
battery for the assessment 
of neuropsychological status 
(RBANS): Clinical utility in a 
traumatic brain injury 
sample. The Clinical 
Neuropsychologist, 22 228-
241. 
Examine clinical utility, sensitivity 
and specificity of RBANS in TBI 
compared to another clinical 
group. 
Hypotheses: 1) RBANS index and 
total score would be able to 
differentiate TBI patients. 2) 
Attention index would show 
largest impairment in TBI group. 
N = 51 TBI consecutive referrals to 
rehab hospital; 28 male, 23 female; 
mean age 38.5 (SD 14.4, range 20-70); 
mean education years 13.1 (SD 1.9); 
35 White, 16 Minority ethnic; injury 
onset months 63.3 (SD 92.3, range 1 – 
312). Mostly moderate-severe TBI. 
 
N = 34 control group mixture of 
clinical/non clinical without brain 
injury; 13 male, 21 female; mean age 
44.9 (SD 14.5, range 19-71); mean 
education years 13.8 (SD 2.8). 
T-tests: Significant differences (P<0.001) on all index and 
total scores between TBI and control group, such that TBI 
performed worse. 
Sensitivity/specificity/LR 
RBANS cut-off <85 (1 SD) (<78 (1.5SD)) 
Immediate memory: 0.63 (0.33); 0.85 (1.0); 4.2 (33) 
Visuospatial: 0.43 (0.28); 0.94 (1.0); 7.2 (28) 
Language: 0.53 (0.29); 0.97 (1.0); 17.7 (29) 
Attention: 0.69 (0.55); 0.79 (0.94); 3.3 (9.2) 
Delayed memory: 0.67(0.45 ); 0.85 (0.91); 4.5 (5.0) 
Total: 0.82(0.51); 0.94(1.0); 13.7(51). 
PPV/NPV/OCC: 
RBANS cut-off <85 (1 SD) (<78 (1.5SD)) 
Immediate memory: 86.5 (100); 60.4 (50); 71.8 (60) 
Visuospatial: 91.7 (100); 52.5 (47.9); 63.5 (56.5) 
Language: 96.4 (100); 57.9 (48.6); 70.6 (57.6) 
Attention: 83.3 (93.3); 62.8 (58.2); 72.9 (70.6) 
Delayed memory: 87.2(88.5); 63(52.5); 74.1(63.5) 
Total: 95.5 (100); 78 (56.7); 87.1 (70.6) 
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Nabors, N. A, Millis, S, R., & 
Rosenthal, M. (1997). Use of 
the Neurobehavioural 
Cognitive Status 
Examination (Cognistat) in 
traumatic brain injury. The 
Journal of Head Trauma 
Rehabilitation, 12, 79-84.  
Assess clinical utility and 
concurrent validity of Cognistat 
with other neuropsychological 
tests: TMT; token test; CVLT; 
logical memory WMS-R; Block 
design; and WCST 
N = 45 TBI; 35 male, 6 female; mean 
age 39.5 (SD15.7); 82% African 
American; Mean education 10.4 years 
(SD 3.0); 47% mild, 18% moderate, 
29% severe; mean injury onset 34.7 
days (SD 25.5, range 6-66); 11 left 
hemisphere, 10 right hemisphere, 8 
bilateral. 
Pearson zero-order correlations: 
Cognistat total score related to education but not to injury 
severity variables. 
Cognistat attention – TMT: r = -0.33, p<0.05; Cognistat 
comprehension – token test: r = 0.3, p<0.05; Cognistat 
memory – CVLT: r = 0.68, p<0.001 and WMS-R: r = 0.43, 
p<0.05; Cognistat construction – Block design: r = 0.54, 
p<0.005. No significant association cognistat reasoning – 
Wisconsin. 
Pachet, A. K. (2007). 
Construct validity of the 
Repeatable Battery of 
Neuropsychological Status 
(RBANS) with acquired brain 
injury patients. Clinical 
Neuropsychologist, 21, 286-
293. 
Examine psychometric properties 
of RBANS in comparison to 
extensive neuropsychological 
battery. 
Reference tests: CVLT; logical 
memory WMS-III; RCFT; digit-
span; SDMT; WCST; GPT; FTT; 
TMT; Block design. 
N = 37 ABI patients long-term rehab 
facility; 29 male, 8 female; mean age 
42.65 (SD13.01, range 19-65); mean 
education years 11.59 (SD 1.99); 16 
closed head injury, 14 cerebrovascular 
accident, 3 meningitis, 4 anoxic; mean 
injury onset months 9.75 (range 3-26); 
90% severe injury. 
Pearson correlations: 
All subtests (bar figure copy/recall - RCFT) reached 
significance, r = 0.61 – 0.78. 
Most index scores significantly correlated with reference 
tests at p<0.005 level except SDMT/TMT with attention; 
RCFT with immediate/delayed memory or visuospatial; TMT 
with visuospatial. 
3 unmatched tests (TMT; FTT & GPT) correlated with one or 
more of RBANS subtest. WCST & block design did not 
correlate with any RBANS subtest. 
 
Temple, R. O., Zgaljardic, D. 
J., Abreu, B. C., Seale, G. S., 
Ostir, G. V., Ottenbacher, K. 
J. (2009). Ecological validity 
of the neuropsychological 
assessment battery 
Evaluate ecological validity of 
NAB-SM by assessing the 
relationship between the NAB-
SM and the FIM in TBI patients. 
N = 70; 57 male, 13 female; mod-
severe TBI; mean age 36.0 (SD 13.6); 
mean education years 12.1 (SD 2.2); 
47 Caucasian, 14 Hispanic, 8 African 
American, 1 Asian; mean injury inset 
1.7 years (SD 4.0). 
Hierarchical regression: The NAB-SM was significantly 
associated with FIM total, motor and cognitive scales over 
and above effects of sex and age. 
NAB total accounted for 26% of variance in FIM total, 11% 
FIM-motor, and 53% FIM-cognitive. 
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screening module in post-
acute brain injury 
rehabilitation. Brain Injury, 
23, 45-50.  
NAB Spatial independently associated with FIM total and 
motor. NAB language, memory and spatial independently 
associated with FIM-cognitive. 
 
Wallace, J. J., Caroselli, J. S., 
Scheibel, R. S., & High, W. 
M. (2000). Predictive validity 
of the neurobehavioural 
cognitive status examination 
(NCSE) in a post-acute 
rehabilitation setting 
Examine 1) association between 
overall NCSE (Cognistat) and 
neuropsychological test 
performance. 2) Convergent 
validity of NCSE with similar 
neuropsychological tests. 3) 
Concurrent predictive validity of 
NCSE with neuropsychological 
tests. 
Reference tests: WAIS-R; MAE; 
JOLO; CVLT; WMS-R. 
N = 48 severe TBI admitted to rehab 
service; 31 male, 17 female; mean age 
29.8 (SD 11.3); mean education years 
12.4 (SD 1.4); mean injury onset days 
113.3 (SD 82.6). 
Correlation coefficients: 
No. impaired performance on NCSE correlated with no. 
impaired performance on neuropsych tests: r=0.56, p<0.001 
Kappa statistics: Agreement between NCSE and neuropsych 
tests for indicating impairment = 0.79, kappa statistic 0.45, 
sensitivity 0.92, specificity 0.22 
Significant correlations found for all paired tests, ranging 
from r=0.32 (Attention-WAIS-R digit span) to r=0.66 
(Construction-WAIS-R Block design); except similarities-
WAIS-R similarities and judgement-WAIS-R Comprehension.  
Kappa statistics: Classification agreement between paired 
tests poor except construction-WAIS-R Block design. 
 
Wilde, M. C. (2006).The 
validity of the repeatable 
battery of 
neuropsychological status in 
acute stroke. 
Examine interrelationships 
between index score and factorial 
validity of the RBANS. 
Reference tests: COWAT, VFD, 
CIM, MMSE. 
N = 120 ischemic stroke patients 
admitted to rehab hospital; 106 
females, 104 males; mean age 61.91 
(SD 13.97); mean education years 
12.27 (SD 3.01); 104 Caucasians, 88 
African Americans, 16 Hispanic, 2 
Asian; mean injury onset days 8.90 (SD 
10.58); 77 left hemisphere, 92 right 
hemisphere, 41 bilateral. 
Pearson correlation coefficients: All index scores were 
significantly correlated with each other and the total index 
score ;r’s Ϭ.Ϯ5 – Ϭ.85, p’s <Ϭ.ϬϬϭͿ. 
Factorial Validity:  
2-factor solution accounted for 61% variance: 
language/verbal memory factor and visuospatial/visual 
memory factor. 
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External validity: 
Lang factor correlated significantly with COWAT (r (43) 
=0.65, p<0.001) and MMSE (r (203) =0.57, p<0.001). 
Visual factor correlated significantly with COWAT (r (43) 
=0.30, p<0.05); VFD (r (26) =0.60, p<0.001) and MMSE (r 
(203) =0.52, p<0.001). 
T-tests: Right hemisphere performed significantly better on 
language factor and worse on visual factor than left 
hemisphere. 
 
Wilde, M. C. (2010). Lesion 
location and repeatable 
battery for the assessment 
of neuropsychological status 
performance in acute 
ischemic stroke. The Clinical 
Neuropsychologist, 24, 57-
69. 
Examine the relationship 
between lesion side and location 
on the RBANS index and subtest 
performance. 
Hypotheses: 1) left hemisphere 
stroke would perform 
significantly better on 
visuospatial/constructional and 
attention indexes. 2) Right 
hemisphere stroke patients 
better immediate/delayed 
memory and language. 3) 
Subcortical better than cortical 
on language and 
immediate/delayed memory. 4) 
Cortical better than subcortical 
on attention and 
N = 164 ischemic stroke (part of larger 
sample 471 consecutive admissions to 
rehab); 81 female, 83 male; mean age 
61.28 (SD 13.94); mean education 
years 12.57 (SD 2.85); mean injury 
onset days 8.82 (SD 9.06); 78 
Caucasian, 73 African American, 10 
Hispanic, 3 Asian; 63 left hemisphere, 
76 right hemisphere, 25 bilateral; 93 
subcortical lesions, 70 cortical lesions. 
MANOVA: statistically significant main effects for side and 
location, no interaction. 
Right hemisphere better language, attention, and 
immediate/delayed memory. 
Left hemisphere better visuospatial/constructional. 
Subcortical significantly better than cortical on 
visuospatial/constructional. 
Right hemisphere better: list learning, story memory, list 
recognition, semantic fluency, digit span. 
Left hemisphere better figure copy and line orientation. 
Subcortical better figure copy, line orientation, coding, story 
recall and figure recall. 
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visuospatial/constructional. 
 
 
Zgaljardic, D. J., & Temple, R. 
O. (2010). Reliability and 
validity of the 
Neuropsychological 
Assessment Battery-
Screening Module (NAB-SM) 
in a sample of patients with 
moderate to severe 
acquired brain injury. 
Applied Neuropsychology, 
17, 27-36.  
Provide preliminary data on the 
internal consistency and 
construct validity of the NAB-SM 
in patients with moderate-sever 
ABI. 
Reference tests: 
Matched: digit-span, tokens test, 
BNT, logical memory, visual 
reproduction, visual form 
discrimination test, block design, 
COWAT.  
Unmatched: TMT, digit-symbol 
coding, RAVLT, WCST. 
N = 42 patients ABI; 31 males, 11 
females; mean age 41.8 (SD 15.1); 
mean education years 13.4 (SD 2.7); 
26 White, 9 Hispanic, 6 Black, 1 Asian; 
24 TBI, 18 CVA; mean injury onset year 
0.77 (SD 1.1). 
IŶterŶal ĐoŶsisteŶĐy: ChroŶďaĐh’s alpha: 
Total score 0.60, attention 0.39, language 0.4, memory 0.42, 
spatial -0.14, executive -0.37. 
Construct validity: Pearson product moment correlation 
coefficients: 
10/19 significant correlations (p<0.05) between NAB-SM raw 
index/total scores and Neuropsych tests. 
NAB-Total correlated with at least one neuropsych test from 
each cognitive domain. Some evidence of convergent 
validity for all indices except executive function which did 
not correlate with any executive neuropsych tests. 
NAB-SM subtests correlated with matched neuropsych tests 
except shape learning & visual reproduction. 
Unmatched tests also correlated with exception of NAB 
digits forward and NAB visual discrimination. 
 
 
Zgaljardic, D. J., Yancy, S., 
Temple, R. O., Watford, M. 
F., & Miller, R. (2011). 
Ecological validity of the 
screening module and the 
Assess ecological validity of the 
NAB (DL & SM) in patients with 
moderate to severe TBI 
Reference test: MPAI-4 
N = 47 (32 men, 15 women); mean age 
– 31.7 (SD – 11.4); mean educational 
attainment = 12.7 (SD = 2.3); 26 
Caucasian, 16 Hispanic, 3 African 
American, 2 Asian; Injury onset mean 
Linear regression analyses: NAB-SM Total index score 
significantly associated with MPAI-4 Total score, F(1, 45) = 
5.3, p=.026. 
NAB-SM Total index score significantly associated with 
Ability subtotal score, F(1,45)=5.3, p=.027 and Participation 
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daily living tests of the 
neuropsychological 
assessment battery using 
mayo-portland adaptability 
inventory-4 in post-acute 
brain injury rehabilitation. 
Rehabilitation Psychology, 
56, 359-365. 
= 16.6 months (SD = 26.6), premorbid 
IQ mean = 97.4 (SD = 8.0). Diagnosis 
moderate-severe TBI (GCS 3-12, LOC 
>30 min &/or +ve neuroimaging) 
subtotal score, F(1, 45)=7.8, p=.008. 
NAB-SM Cognitive index scores were significantly associated 
MPAI-Total and Ability and Participation scores (F's>3.0, 
p’s<.ϬϮϮͿ. 
NAB-DL significantly associated with MPAI-4 Total, Ability 
and PartiĐipatioŶ sĐores ;F’s>Ϯ.8, p’s<.ϬϮϮͿ. 
No associations with adjustment score of mpai-4. 
 
MMSE = Mini-Mental State Examination; TMT = Trail Making Test; NAB = Neuropsychological Assessment Battery (DL = daily living, SM = Screening module); (M)TBI = 
(Mild) traumatic brain injury; ABI = acquired brain injury; GCS = Glasgow Coma Scale; LOC = loss of consciousness; MPAI-4 = Mayo-Portland Adaptability Inventory-4; FIM = 
Functional Independence Measure; ABI = acquired brain injury; ACE-R = AddeŶďrooke’s CogŶitiǀe Examination-Revised; WMS (III/R) = Wechsler Memory Scales 
(three/revised); BIT = behavioural inattention test; ROC = receiver operating curves; PPV = positive predictive value, NPV = negative predictive value; AUC = area under the 
curve; LR = likelihood ratioŶ; PSI = persoŶ separatioŶ iŶdeǆ; RPM = RaǀeŶ’s Progressiǀe MatriĐes; RCFT = ReǇ-Osterreith Complex Figure Test; COWAT = Controlled Word 
Association Test; CVLT = California verbal learning test; RBANS = repeatable battery for the assessment of neuropsychological status; SDMT = symbol digit modalities test; 
WCST = Wisconsin card sorting test; GPT = grooved pegboard test; FTT = finger tapping test; EXIT = executive interview; BDAE = Boston Diagnostic Aphasia Exam; RBMT = 
rivermead behavioural memory test; WAIS (III/R) = Wechsler adult intelligence scale (three/revised); NCSE/Cognistat = neurobehavioural cognitive status examination; 
WRAT-3 = wide range achievement test-3; TOMM = test of memory malingering; BDI-II = Beck Depression Inventory-2; BPD = borderline personality disorder; FAI = 
frenchay activity index; CHART = Craig Handicap and Assessment Reporting Technique; BVRT = Benton visual retention test; MAE = multilingual aphasia examination; JOLO 
= judgment of line orientation; VFD = visual form discrimination test; CIM = complex ideational material; MANOVA = multiple analysis of variance; BNT = Boston naming 
test; RAVLT = Rey auditory verbal learning test. 
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Index Subtest (Total score) 
Orientation Index (ORI) Orientation to Person (4) 
 Orientation to Time (8) 
 Orientation to Place (4) 
 Orientation to Condition (2) 
 Orientation to Prime Minister/President (2) 
 Time Estimation (2) 
Attention and Concentration Index (ACI) Digit Span Forward (6) 
 Digit Span Backward (6) 
 Sustained and Divided Listening I (10) 
 Sustained and Divided Listening II (10) 
 Counting Backwards (6) 
 Monetary Calculations (8) 
Memory and Learning Index (MLI) Object Recall (6) 
 Figures Recall (11) 
 List Learning (18) 
 List Recall (6) 
 List Recognition (12) 
 Word-Symbol Paired Associates (14) 
Language Index (LAI) Repetition (6) 
 Naming (12) 
 Yes/No Questions (6) 
 Following Directions (6) 
 Reading (6) 
 Writing Sentences (5) 
 Similarities (12) 
Visuo-motor Performance Index (VPI) Object Recognition (3) 
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 Spatial Decision (12) 
 Unusual Views (4) 
 Figures Copy (16) 
 Letter-Number Coding (12) 
 Figures Recognition (3) 
 Facial Expressions (4) 
 3 and 1 Concept Test (16) 
Processing Speed Index (PSI) Letter-Number Coding (12) 
 Counting Backwards (6) 
 Spatial Decision (12) 
 Monetary Calculations (8) 
 Sustained and Divided Listening II (10) 
Conceptual Flexibility Index (CFI) 3 and 1 Concept Test (16) 
 Similarities (12) 
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Appendix F: Consent form 
 
 
CONSENT FORM 
 
Participant identification number for this trial: 
Title of study: Norming and psychometric analysis of a cognitive test 
Name of Researcher: Gerald H. Burgess, Psy, D., Clinical Psychologist 
Please initial boxes: 
 
  
 
 
 
 
 
 
 
 
 
 
 
__________________ __________________ __________________ 
Participant   Date    Signature 
 
__________________ __________________ ___________________ 
Person taking consent  Date    Signature 
 
Visit the website http://www.pansa.synthasite.com for information relating to the progress 
and findings of this study
 
 
 
 
I confirm that I have read and understand the information sheet for the 
above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason 
I understand that the relevant data collected during the study may be 
reviewed by the primary investigator (Dr Gerald Burgess) and members 
of the research team with permissions of the primary investigator where 
it is relevant to the research, but that no personally identifying 
information will be attached to this data. I give permission for the 
primary investigator and research team to have access to this data. 
I agree to take part in the above study 
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participant group and form 
 
 
  
Group/Form ABI LTNC Controls 
Subtest/index (Highest 
score possible) 
A B A B A B 
Orientation to Person (4) 3.37 
(.88) 
2-4 
3.17 
(1.12) 
1-4 
3.86 
(.45) 
2-4 
3.57 
(.79) 
2-4 
4.00 
(.00) 
4-4 
3.97 
(.26) 
2-4 
Orientation to Time (8) 6.10 
(2.24) 
1-8 
5.08 
(3.03) 
0-8 
7.32 
(1.68) 
1-8 
7.00 
(1.92) 
3-8 
7.98  
(.13) 
7-8 
8.00 
(.00) 
8-8 
Orientation to Place (4) 3.45 
(.94) 
0-4 
3.25 
(.87) 
1-4 
3.86 
(.45) 
2-4 
3.43 
(.79) 
2-4 
4.00 
(.00) 
4-4 
4.00 
(.00) 
4-4 
Orientation to Condition 
(2) 
1.61 
(.64) 
0-2 
.92 
(.90) 
0-2 
1.68 
(.72) 
0-2 
1.71 
(.49) 
1-2 
2.00 
(.00) 
2-2 
2.00 
(.00) 
2-2 
Orientation to Prime 
Minister/President (2) 
1.28 
(.69) 
0-2 
.83 
(.91) 
0-2 
1.63 
(.54) 
0.5-2 
1.14 
(.90) 
0-2 
1.94 
(.18) 
1-2 
1.73 
(.51) 
0-2 
Time Estimation (2) 1.47 
(.77) 
0-2 
1.67 
(.65) 
0-2 
1.46 
(.74) 
0-2 
1.29 
(.95) 
0-2 
1.97 
(.25) 
0-2 
1.89 
(.32) 
1-2 
Digit Span Forward (6) 4.10 
(1.52) 
1-6 
3.67 
(1.97) 
1-6 
4.43 
(1.35) 
1-6 
4.57 
(.79) 
4-6 
5.25 
(1.03) 
2-6 
5.44 
(.65) 
4-6 
Digit Span Backward (6) 4.06 
(1.84) 
0-6 
3.58 
(1.68) 
0-6 
4.93 
(1.12) 
2-6 
4.43 
(.98) 
3-6 
5.23 
(.82) 
3-6 
5.43 
(.83) 
3-6 
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Sustained and Divided 
Listening I (10) 
9.02 
(2.19) 
1-10 
7.25 
(3.57) 
0-10 
9.29 
(1.21) 
5-19 
10.00 
(.00) 
10-10 
9.75 
(.87) 
6-10 
9.92 
(.28) 
9-10 
Sustained and Divided 
Listening II (10) 
7.33 
(2.86) 
0-10 
4.50 
(3.53) 
0-10 
8.07 
(2.23) 
3-10 
8.14 
(1.46) 
6-10 
9.49 
(1.09) 
6-10 
9.82 
(.47) 
8-10 
Counting Backwards (6) 4.43 
(1.53) 
0-6 
2.92 
(1.88) 
0-6 
4.61 
(1.64) 
0-6 
4.71 
(1.60) 
2-6 
5.20 
(1.08) 
2-6 
5.34 
(.89) 
3-6 
Monetary Calculations (8) 5.55 
(2.25) 
0-8 
4.17 
(3.07) 
0-8 
6.00 
(2.24) 
1-8 
6.29 
(2.29) 
3-8 
7.03 
(1.34) 
4-8 
6.98 
(1.46) 
2-8 
Object Recall (6) 3.63 
(2.10) 
0-6 
1.92 
(2.19) 
0-6 
4.96 
(1.04) 
3-6 
4.14 
(2.55) 
0-6 
5.30 
(.67) 
4-6 
5.31 
(.56) 
4-6 
Figures Recall (11) 6.00 
(3.97) 
0-11 
2.92 
(3.32) 
0-8 
8.54 
(3.25) 
0-11 
6.00 
(4.28) 
0-11 
8.74 
(2.14) 
0-11 
9.30 
(1.53) 
6-11 
List Learning (18) 12.71 
(3.48) 
2-18 
9.75 
(4.56) 
4-18 
14.50 
(2.35) 
8-18 
13.43 
(2.36) 
11-17 
15.72 
(1.64) 
12-18 
16.08 
(1.43) 
12-18 
List Recall (6) 2.96 
(2.12) 
0-6) 
1.75 
(2.14) 
0-6 
4.93 
(1.41) 
1-6 
3.86 
(2.73) 
0-6 
4.89 
(1.24) 
2-6 
5.43 
(.85) 
3-6 
List Recognition (12) 10.51 
(1.82) 
5-12 
8.17 
(3.54) 
0-12 
11.54 
(1.00) 
8-12 
11.29 
(.95) 
10-12 
11.77 
(.69) 
9-12 
11.89 
(.45) 
10-12 
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Word-Symbol Paired 
Associates (14) 
9.08 
(4.41) 
0-14 
4.75 
(4.90) 
0-13 
11.39 
(2.95) 
4-14 
11.43 
(4.32) 
3-14 
12.95 
(2.39) 
6-14 
13.61 
(.80) 
11-14 
Repetition (6) 4.55 
(1.53) 
1-6 
3.50 
(1.58) 
1-6 
5.04 
(.84) 
3-6 
4.57 
(1.13) 
3-6 
5.52 
(.62) 
4-6 
5.33 
(.63) 
3-6 
Naming (12) 11.00 
(2.47) 
0-12 
7.58 
(4.50) 
0-12 
11.71 
(.60) 
10-12 
11.00 
(2.24) 
6-12 
12.00 
(.00) 
12-12 
11.97 
(.18) 
11-12 
Yes/No Questions (6) 5.57 
(.76) 
3-6 
4.58 
(1.31) 
3-6 
5.71 
(.54) 
4-6 
5.57 
(.79) 
4-6 
5.97 
(.18) 
5-6 
5.97 
(.18) 
5-6 
Following Directions (6) 4.94 
(1.36) 
1-6 
3.75 
(1.49) 
1-6 
4.89 
(1.17) 
2-6 
5.29 
(1.11) 
3-6 
5.87 
(.34) 
5-6 
5.70 
(.50) 
4-6 
Reading (6) 5.24 
(1.39) 
0-6) 
3.58 
(2.43) 
0-6 
5.64 
(1.19) 
0-6 
5.57 
(.79) 
4-6 
5.90 
(.44) 
4-6 
5.90 
(.44) 
4-6 
Writing Sentences (5) 3.51 
(1.34) 
0-5 
2.17 
(1.75) 
0-5 
3.79 
(1.03) 
0-5 
2.71 
(1.98) 
0-5 
4.56 
(.62) 
3-5 
4.30 
(.69) 
3-5 
Similarities (12) 9.16 
(3.17) 
0-12 
6.00 
(4.29) 
0-12 
10.68 
(1.79) 
5-12 
10.86 
(1.07) 
9-12 
11.36 
(1.08) 
8-12 
11.21 
(1.00) 
8-12 
Object Recognition (3) 2.51 
(.65) 
1-3 
2.08 
(1.24) 
0-3 
2.86 
(.59) 
0-3 
2.42 
(1.13) 
0-3 
2.93 
(.25) 
2-3 
2.80 
(.40) 
2-3 
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Spatial Decision (12) 8.35 
(2.80) 
0-12 
5.17 
(4.04) 
0-12 
9.36 
(2.63) 
3-12 
9.14 
(3.02) 
4-12 
10.89 
(1.94) 
6-12 
10.80 
(2.10) 
4-12 
Unusual Views (4) 3.43 
(.89) 
0-4) 
2.67 
(1.56) 
0-4 
3.68 
(.91) 
0-4 
3.43 
(.79) 
2-4 
3.64 
(.52) 
2-4 
3.75 
(.51) 
2-4 
Figures Copy (16) 13.04 
(3.42) 
0-16 
10.25 
(6.17) 
0-16 
14.32 
(2.47) 
8-16 
13.29 
(2.14) 
9-16 
14.11 
(1.71) 
7-16 
14.13 
(1.25) 
12-16 
Letter-Number Coding 
(12) 
5.94 
(3.26) 
0-12 
3.67 
(3.63) 
0-11 
7.68 
(3.41) 
1-12 
6.71 
(3.35) 
1-11 
11.34 
(1.34) 
7-12 
11.44 
(1.10) 
8-12 
Figures Recognition (3) 2.04 
(.98) 
0-3 
1.67 
(1.07) 
0-3 
2.61 
(.69) 
1-3 
2.14 
(1.07) 
0-3 
2.69 
(.53) 
1-3 
2.80 
(.51) 
1-3 
Facial Expressions (4) 2.90 
(1.21) 
0-4 
2.17 
(1.34) 
0-4 
3.14 
(1.04) 
0-4) 
2.86 
(1.07) 
1-4 
3.66 
(.66) 
1-4 
3.67 
(.60) 
2-4 
3 and 1 Concept Test (16) 12.51 
(3.09) 
4-16 
9.33 
(6.10) 
0-16 
14.18 
(3.04) 
4-16 
15.43 
(.79) 
14-16 
15.84 
(.52) 
14-16 
15.59 
(.78) 
13-16 
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ORI (22) 17.28 
(4.71) 
6-22 
14.92 
(6.10) 
5-22 
19.80 
(3.62) 
5.5-22 
18.14 
(4.14) 
12-22 
21.89 
(.33) 
20-22 
21.58 
(.77) 
19-22 
ACI (46) 34.39 
(8.75) 
5-46 
26.08 
(12.42) 
6-45 
37.32 
(7.13) 
22-46 
38.12 
(5.43) 
30-43 
41.95 
(3.31) 
32-46 
42.93 
(2.34) 
34-46 
MLI (67) 44.90 
(15.24) 
14-66 
29.25 
(15.98) 
10-61 
55.86 
(8.86) 
32-66 
50.14 
(15.70) 
24-62 
59.36 
(5.60) 
34-66 
61.61 
(4.06) 
51-67 
LAI (53) 43.98 
(9.53) 
9-53 
31.17 
(13.62) 
11-51 
47.46 
(4.22) 
38-52 
45.57 
(7.81) 
29-52 
51.18 
(1.77) 
47-53 
50.38 
(2.01) 
42-53 
VPI (70) 50.71 
(13.23) 
9-69 
37.00 
(21.97) 
0-63) 
57.82 
(11.50) 
20-70 
55.43 
(9.29) 
40-64 
65.20 
(3.27) 
55-70 
65.00 
(4.22) 
54-70 
PSI (48) 31.59 
(9.40) 
0-47 
20.42 
(21.97) 
0-63) 
35.71 
(10.21) 
13-48 
35.00 
(8.96) 
17-44 
43.95 
(3.48) 
36-48 
44.39 
(3.55) 
35-48 
CFI (28) 21.67 
(5.69) 
6-28 
15.33 
(8.77) 
2-27 
24.86 
(4.06) 
14-28 
26.29 
(1.70) 
24-28 
27.20 
(1.28) 
23-28 
26.80 
(1.53) 
21-28 
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